Human Biomonitoring for Environmental Chemicals

Human Biomonitoring for Environmental Chemicals

Volumn , Issue , 2006, Pages 1-291

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85011385846     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.17226/11700     Document Type: Book

References (528)

1. ACGIH (American Conference of Governmental Industrial Hygienists). 2001. Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices, 7th Ed. American Conference of Governmental Industrial Hygienists, Cincinnati, OH.
2. CBRC (Commonweal Biomonitoring Resources Center). 2005. Taking it all in: Documenting Chemical Pollution in Californians Through Biomonitoring. Commonweal Biomonitoring Resources Center, Bolinas, CA. August 30, 2005. 50pp [online]. Available: http:// www.commonweal.org/programs/brc/Taking_It_All_In.html [accessed Nov. 16, 2005].
3. CDC (Centers for Disease Control and Prevention). 2003. Second National Report on Human Exposure to Environmental Chemicals. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http://www.jhsph.edu/ephtcenter/Second%20Report.pdf [accessed Nov. 16, 2005].
4. CDC (Centers for Disease Control and Prevention). 2005. Third National Report on Human Exposure to Environmental Chemicals. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http:// www.cdc.gov/exposurereport/3rd/ [accessed Nov. 16, 2005].
5. EPA (U.S. Environmental Protection Agency). 2006. Glossary of IRIS Terms. Integrated Risk Information System, U.S. Environmental Protection Agency, Washington, DC [online]. Available: http://www.epa.gov/iris/gloss8.htm [accessed May 12, 2006].
6. Gan, J., P.L. Skipper, M. Gago-Dominguez, K. Arakawa, R.K. Ross, M.C. Yu, and S.R. Tannenbaum. 2004. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J. Natl. Cancer Inst. 96(19):1425-1431.
7. GAO (U.S. General Accounting Office). 2000. Toxic Chemicals: Long-term Coordinated Strategy Needed to Measure Exposures in Humans. GAO/HEHS-00-80. U.S. General Accounting Office, Washington, DC. May 2000 [online]. Available: http://www.gao.gov/ new.items/he00080.pdf. [accessed Nov. 16, 2005].
8. GAO (U.S. General Accounting Office). 2005. Chemical Regulation: Options Exist to Improve EPA's Ability to Assess Health Risks and Manage its Chemical Review Program. GAO-05-458. U.S. General Accounting Office, Washington, DC. June 2005 [online]. Available: http://www.gao.gov/new.items/d05458.pdf [accessed Nov. 16, 2005].
9. Hecht, S.S. 2003. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer 3(10):733-744.
10. IC Wales. 2005. Chemicals found in stars' blood. IC Wales, IC Network, Trinity Mirror plc. May 16, 2005 [online]. Available: http://icwales.icnetwork.co.uk/0100news/0600uk/ tm_objectid=15520784&method=full&siteid=50082&headline=chemicals-found-instars- blood-name_page.html [accessed Nov. 16, 2005].
11. Jackson, R., P. Locke, J. Pirkle, F.E. Thompson, and D. Sussman. 2002. Will biomonitoring change how we regulate toxic chemicals? J. Law Med. Ethics 30(3):177-183.
12. Joseph, A.M., S.S. Hecht, S.E. Murphy, S.G. Carmella, C.T. Le, Y. Zhang, S. Han, and D.K. Hatsukami. 2005. Relationship between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol. Biomarkers Prev. 14(12):2963-2968.
13. Kensler, T.W., J.G. Chen, P.A. Egner, J.W. Fahey, L.P. Jacobson, K.K. Stephenson, L. Ye, J.L. Coady, J.B. Wang, Y. Wu, Y. Sun, Q.N. Zhang, B.C. Zhang, Y.R. Zhu, G.S. Qian, S.G. Carmella, S.S. Hecht, L. Benning, S.J. Gange, J.D. Groopman, and P. Talalay. 2005. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 14(11 Pt 1):2605-2613.
14. Maier, A., R.E. Savage, Jr., and L.T. Haber. 2004. Assessing biomarker use in risk assessment: A survey of practitioners. J. Toxicol. Environ. Health A 67(8-10):687-695.
15. McNaught, A.D., and A. Wilkinson. 1997. Compendium of Chemical Terminology: IUPAC Recommendations, 2nd Ed. Malden, MA: Blackwell Science.
16. Metcalf, S.W., and K.G. Orloff. 2004. Biomarkers of exposure in community settings. J. Toxicol. Environ. Health A 67(8-10):715-726.
17. Morgan, M.S. 1997. The biological exposure indices: A key component in protecting workers from toxic chemicals. Environ. Health Perspect. 105(Suppl. 1):105-115.
18. Needham, L.L., H. Ozkaynak, R.M. Whyatt, D.B. Barr, R.Y. Wang, L. Naeher, G. Akland, T. Bahadori, A. Bradman, R. Fortmann, L.J. Liu, M. Morandi, M.K. O'Rourke, K. Thomas, J. Quackenboss, P.B. Ryan, and V. Zartarian. 2005. Exposure assessment in the National Children's Study: Introduction. Environ. Health Perspect. 113(8):1076-1082.
19. NRC (National Research Council). 1987. Biologic markers in environmental health research. Environ Health Perspect. 74:3-9.
20. NRC (National Research Council). 1991. Monitoring Human Tissues for Toxic Substances. Washington, DC: National Academy Press.
21. OMB Watch. 2005. Minnesota considers "Biomonitoring" to protect public health. OMB Watcher 6(17) [online]. Available: http://www.ombwatch.org/article/articleview/3065/1/ 97?TopicID=1 [accessed Nov. 18, 2005].
22. Pirkle, J.L., L.L. Needham, and K. Sexton. 1995. Improving exposure assessments by monitoring human tissues for toxic chemicals. J. Expo. Anal. Environ. Epidemiol. 5(3): 405-424.
23. Qian, G.S., R.K. Ross, M.C. Yu, J.M. Yuan, Y.T. Gao, B.E. Henderson, G.N. Wogan, and J.D. Groopman. 1994. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 3:3-10.
24. Rappaport, S.M., S. Waidyanatha, K. Yeowell-O'Connell, N. Rothman, M.T. Smith, L. Zhang, Q. Qu, R. Shore, G. Li, and S. Yin. 2005. Protein adducts as biomarkers of human metabolism. Chem Biol Interact. 153-154:103-109.
25. Reddy, M.B., R.H. Yang, H.J. Clewell, and M.E. Andersen. 2005. Physiologically Based Pharmacokinetic Modeling: Science and Applications. Hoboken, NJ: John Wiley & Sons.
26. Risk Policy Report. 2005. California Biomonitoring Bill Clears Hurdle, but Faces Heavy Opposition. Inside EPA's Risk Policy Report 12(13):9-10. April 5, 2005.
27. Schulte, P.A., and F.P. Perera, eds. 1993. Molecular Epidemiology: Principles and Practices. San Diego, CA: Academic Press.
28. Schulte, P.A., and M.H. Sweeney. 1995. Ethical considerations, confidentiality issues, rights of human subjects, and uses of monitoring data in research and regulation. Environ. Health Perspect. 103(Suppl. 3):69-74.
29. Sexton, K., L.L. Needham, and J.L. Pirkle. 2004. Human biomonitoring of environmental chemicals: Measuring chemicals in human tissue is the "gold standard" for assessing the people's exposure to pollution. Am. Sci. 92(1):38-45.
30. WHO (World Health Organization). 2001. Biomarkers in Risk Assessment: Validity and Validation. Environmental Health Criteria 222. Geneva: World Health Organization. 238pp [online]. Available: http://www.inchem.org/documents/ehc/ehc/ehc222.htm [accessed Nov. 21, 2005].
31. Wilhelm, M., U. Ewers, and C. Schulz. 2004. Revised and new reference values for some trace elements in blood and urine for human biomonitoring in environmental medicine. Int. J. Hyg. Environ. Health 207(1):69-73.
32. WWF (World Wildlife Fund). 2002. Bad Blood? Survey of Chemicals in the Blood of European Ministers. Brussels: World Wildlife Fund [online]. Available: http://worldwildlife.org/toxics/pubs/badblood.pdf [accessed Nov. 18, 2005].
33. WWF (World Wildlife Fund). 2003. Contamination: The Results of WWF's Biomonitoring Survey. Brussels: World Wildlife Fund [online]. Available: http://www.wwf.org.uk/file library/pdf/biomonitoringresults.pdf [accessed Nov. 18, 2005].
34. Yu, M.C., R.K. Ross, K.K. Chan, B.E. Henderson, P.L. Skipper, S.R. Tannenbaum, and G.A. Coetzee. 1995. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers. Cancer Epidemiol. Biomarkers Prev. 4(8):861-864.
35. ACC (American Chemistry Council). 2002. Long-Range Research Initiative. Research Strategy.
36. American Chemistry Council, Arlington, VA. October 2002 [online]. Available: http://www.uslri.com/documents/cat_25/doc_427.pdf [accessed June 3, 2005].
37. Agricultural Health Study. 2005. Agricultural Health Study [online]. Available: http://www.aghealth.org/ [accessed Sept. 26, 2005].
38. Alavanja, M.C., D.P. Sandler, S.B. McMaster, S.H. Zahm, C.J. McDonnell, C.F. Lynch, M. Pennybacker, N. Rothman, M. Dosemeci, A.E. Bond, and A. Blair. 1996. The Agricultural Health Study. Environ. Health Perspect. 104(4):362-369.
39. Albertini, R., M. Bird, N. Doerrer, L. Needham, S. Robison, L. Sheldon, and H. Zenick. In press. The use of biomonitoring data in exposure and human health risk assessment. Environ. Health Perspect. [online]. Available: http://ehp.niehs.nih.gov/docs/2006/9056/ abstract.html [accessed Aug. 21, 2006].
40. Anderson, H.A., C. Falk, L. Hanrahan, J. Olson, V.W. Burse, L. Needham, D. Paschal, D. Patterson, Jr., and R.H. Hill, Jr. 1998. Profiles of Great Lakes critical pollutants: A sentinel analysis of human blood and urine. The Great Lakes Consortium. Environ. Health Perspect. 106(5):279-289.
41. APHL (Association of Public Health Laboratories). 2004. Biomonitoring: Measuring Chemicals in People. May 2004 [online]. Available: http://www.aphl.org/docs/Biomonitoring.pdf [accessed June 3, 2005].
42. APHL (American Public Health Laboratories). 2006. Recent Activities. Biomonitoring in the States: The APHL Minute 1:12-13 [online]. Available: https://www.aphl.org/docs/ newsletter/january_february_3.pdf [accessed Jan. 18, 2006].
43. Baker, B.A., B.H. Alexander, J.S. Mandel, J.F. Acquavella, R. Honeycutt, and P. Chapman. 2005. Farm Family Exposure Study: Methods and recruitment practices for a biomonitoring study of pesticide exposure. J. Expo. Anal. Environ. Epidemiol. 15(6):491-499.
44. Barr, D.B., and J. Angerer. In press. Potential uses of biomonitoring data: A case study using the organophosphorus pesticides chlorpyrifos and malathion. Environ Health Perspect. [online]. Available: http://ehp.niehs.nih.gov/docs/2006/9062/abstract.html [accessed Aug. 21, 2006].
45. Becker, K., C. Schulz, S. Kaus, M. Seiwart, and B. Seifert. 2003. German Environmental Survey 1998 (GerES III): Environmental pollutants in the urine of the German population. Int. J. Hyg. Environ. Health. 206(1):15-24.
46. Birnbaum, L.S., and E.A. Cohen Hubal. In press. Polybrominated diphenyl ethers: A case study for using biomonitoring data to address risk assessment questions. Environ. Health Perspect. [online]. Available: http://ehp.niehs.nih.gov/docs/2006/9061/abstract.html [accessed Aug. 21, 2006].
47. Blair, A., D. Sandler, K. Thomas, J.A. Hoppin, F. Kamel, J. Coble, W.J. Lee, J. Rusiecki, C. Knott, M. Dosemeci, C.F. Lynch, J. Lubin, and M. Alavanja. 2005. Disease and injury among participants in the Agricultural Health Study. J. Agric. Saf. Health 11(2): 141-150.
48. Buck, G.M., P.T. Grace, E.F. Fitzgerald, J.E. Vena, J.M. Weiner, M. Swanson, and M.E. Msall. 2003. Maternal fish consumption and infant birth size and gestation: New York State Angler Cohort Study. Environ. Health 2(1):7-15.
49. Burke, T.A., and K. Sexton. 1995. Integrating science and policy in a National Human Exposure Assessment Survey. J. Expo. Anal. Environ. Epidemiol. 5(3):283-296.
50. Butenhoff, J.L., G.W. Olsen, and A. Pfahles-Hutchens. In press. The applicability of biomonitoring data for perfluorooctanesulfonate (PFOS) to the environmental public health continuum. Environ. Health Perspect. [online]. Available: http://ehp.niehs.nih.gov/docs/ 2006/9060/abstract.html [accessed Aug. 21, 2006].
51. Calafat, A.M., and R.H. McKee. In press. Integrating biomonitoring exposure data into the risk assessment process: Phthalates (diethyl phthalate and di[2-ethylhexyl] phthalate) as a case study. Environ. Health Perspect. [online]. Available: http://ehp.niehs.nih.gov/docs/ 2006/9059/abstract.html [accessed Aug. 21, 2006].
52. CDC (Centers for Disease Control and Prevention). 2003. Second National Report on Human Exposure to Environmental Chemicals. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http://www.jhsph.edu/ephtcenter/Second%20Report.pdf [accessed Nov. 21, 2005].
53. CDC (Centers for Disease Control and Prevention). 2004. CLIA: Subpart R. Enforcement Procedures. Clinical Laboratory Improvement Amendments U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http://www.phppo.cdc.gov/clia/regs/subpart_r.aspx. [accessed Jan. 18, 2006].
54. CDC (Centers for Disease Control and Prevention). 2005. Third National Report on Human Exposure to Environmental Chemicals. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http:// www.cdc.gov/exposurereport/3rd/pdf/thirdreport.pdf [accessed Sept. 26, 2005].
55. CDC (Centers for Disease Control and Prevention). 2006a. Laboratory Response Network. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention [online]. Available: http://www.bt.cdc.gov/lrn/pdf/lrn-overview-presentation.pdf [accessed Jan. 18, 2006].
56. CDC (Centers for Disease Control and Prevention). 2006b. Laboratory Network for Chemical Terrorism. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention [online]. Available: http://www.bt.cdc.gov/lrn/chemical.asp. [accessed Jan. 18, 2006].
57. CMS (Center for Medicare & Medicaid Services). 2005. CLIA Approved Proficiency Testing Programs 2005 [online]. Available: http://63.241.27.79/clia/ptlist.pdf. [accessed April 14, 2006].
58. Commission of the European Communities. 2004. The European Environment & Health Action Plan 2004-2010. Communication from the Commission to the Council, the European Parliament, the European Economic and Social Committee. COM(2004) 416 final. Brussels. June 9, 2004 [online]. Available: http://europa.eu.int/comm/environment/ health/pdf/com2004416.pdf [accessed Nov. 21, 2005].
59. Commonweal. 2005. Taking It All In: Documenting Chemical Pollution in Californians Through Biomonitoring. Commonweal Biomonitoring Center, Bolinas, CA [online]. Available: http://www.commonweal.org/programs/download/TIAI_Lo-Rez.pdf [accessed April 17, 2006].
60. Dellinger, J.A., R.M. Meyers, K.J. Gebhardt, and L.K. Hansen. 1996. The Ojibwa Health Study: Fish residue comparisons for Lakes Superior, Michigan, and Huron. Toxicol. Ind. Health 12(3-4):393-402.
61. ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals). 2005. Guidance for the Interpretation of Biomonitoring Data. Document No. 44. Brussel, Belgium: ECETOC. Nov. 30, 2005.
62. ECNIS. 2005. Environmental Cancer Risk, Nutrition and Individual Susceptibility [online]. Available: http://www.ecnis.org/ [accessed Sept. 26, 2005].
63. Environmental Defence. 2005. Toxic Nation: A Report on Pollution in Canadians. Environmental Defence, Toronto, ON. November 2005 [online]. Available: http://www.environ mentaldefence.ca/toxicnation/report/Rev_English%20Web.pdf [accessed April 17, 2006].
64. EPA (U.S. Environmental Protection Agency). 2005. Human Exposure Measurements: National Human Exposure Assessment Survey (NHEXAS) [online]. Available: http://www.epa.gov/heasd/edrb/nhexas.htm [accessed June 3, 2005].
65. EPA SAB (U.S. Environmental Protection Agency Science Advisory Board). 1999. An SAB Advisory: The National Human Exposure Assessment Survey (NHEXAS) Pilot Studies. EPA-SAB-IHEC-ADV-99-004. U.S. Environmental Protection Agency, Science Advisory Board, Washington, DC. February 1999 [online]. Available: http://www.epa.gov/sab/ pdf/ihea9904.pdf [accessed Nov. 23, 2005].
66. ESBIO (Expert Team to Support Biomonitoring in Europe). 2006. European Pilot Project on HBM (Implementation Group on Human Biomonitoring). European Human Monitoring [online]. Available: http://www.eu-biomonitoring.org/sub/epphbm_main.htm [accessed April 14, 2006].
67. Eskenazi, B., E.A. Gladstone, G.S. Berkowitz, C.H. Drew, E.M. Faustman, N.T. Holland, B. Lanphear, S.J. Meisel, F.P. Perera, V.A. Rauh, A. Sweeney, R.M. Whyatt, and K. Yolton. 2005. Methodologic and logistic issues in conducting longitudinal birth cohort studies: Lessons learned from the Centers for Children's Environmental Health and Disease Prevention Research. Environ. Health Perspect. 113(10):1419-1429.
68. European Commission. 2004. Baseline Report on "Biomonitoring for Children" in the Framework of the European Environment and Health Strategy (COM(2003)338 final). Prepared by the Technical Working Group on Integrated Monitoring. January 9, 2004 [online]. Available: http://www.brussels-conference.org/Download/baseline_report/BR_ Biomonitoring_final.pdf [accessed June 3, 2005].
69. European Commission. 2006. Endocrine Disrupter Research-Ongoing 5th and 6th Framework Projects. European Commission [online]. Available: http://europa.eu.int/comm/ research/endocrine/projects_ongoing_en.html [accessed April 17, 2006].
70. European Union. 2006. Press Release: NewGeneris: A New European Research Project on Children's Health, Food and the Environment [online]. Available: http://www.euractiv.com/29/images/NewGeneris_pr_tcm29-152906.doc [accessed April 24, 2006].
71. Ewers, C., C. Krause, C. Schulz, and M. Wilhelm. 1999. Reference values and human biological monitoring values for environmental toxins. Report on the work and recommendations of the Commission on Human Biological Monitoring of the German Federal Environmental Agency. Int. Arch. Occup. Environ. Health 72(4):255-260.
72. EWG (Environmental Working Group). 2003a. Body Burden: The Pollution in People. Mount Sinai School of Medicine, New York, Environmental Working Group and Commonweal, Bolinas, CA [online]. Available: http://www.ewg.org/reports/bodyburden/toc.php [accessed April 17, 2004].
73. EWG (Environmental Working Group). 2003b. Mothers'Milk: Record Levels of Toxic Fire Retardants Found in American Mothers' Breast Milk. Environmental Working Group [online]. Available: http://www.ewg.org/reports_content/mothersmilk/pdf/mothersmilk_ final.pdf [accessed April 17, 2006].
74. EWG (Environmental Working Group). 2005. Body Burden: The Pollution in Newborns. A Benchmark Investigation of industrial Chemicals, Pollutants, and Pesticides in Human Umbilical Cord Blood. Environmental Working Group and Commonweal [online]. Available: http://www.ewg.org/reports/bodyburden2/ [accessed April 17, 2006].
75. Falk, L., L. Hanrahan, H.A. Anderson, M.S. Kanarek, L. Draheim, L. Needham, and D. Patterson, Jr. 1999. Body burdens levels of dioxins, furans, and PCBs among frequent consumers of Great Lakes sport fish. The Great Lakes Consortium. Environ. Res. 80(2 Pt 2):S19-S25.
76. Farm Family Exposure Study. 2005. Farm Family Exposure Study [online]. Available: http:// www.farmfamilyexposure.org/ [accessed Sept. 26, 2005].
77. Fitzgerald, E.F., D.A. Deres, S.A. Hwang, B. Bush, B.Z. Yang, A. Tarbell, and A. Jacobs. 1999. Local fish consumption and serum PCB concentrations among Mohawk men at Akwesasne. Environ. Res. 80(2 Pt 2):S97-S103.
78. GAO (U.S. General Accounting Office). 2000. Toxic Chemicals: Long-Term Coordinated Strategy Needed to Measure Exposures in Humans. GAO/HEHS-00-80. U.S. General Accounting Office, Washington, DC. May 2000 [online]. Available: http://www.gao.gov/ new.items/he00080.pdf [accessed June 3, 2005].
79. GerES (German Environmental Survey). 2005. Objectives. German Environmental Survey. Federal Environmental Agency, Dessau, Germany [online]. Available: http://www.um weltbundesamt.de/survey-e/objectives.htm [accessed June 3, 2005].
80. German Federal Environmental Agency. 2006. Environmental Specimen Bank [online]. Available: http://www.umweltbundesamt.de/uba-info-daten-e/daten-e/umweltprobenbank-desbundes.htm [accessed July 7, 2006].
81. Gunter, E.W. 1997. Biological and environmental specimen banking at the Centers for Disease Control and Prevention. Chemosphere 34(9/10):1945-1953.
82. Holzman, D. 1996. Banking on tissues. Environ. Health Perspect. 104(6):606-610.
83. Hughes, M.F. In press. Biomarkers of exposure: A case study with inorganic arsenic. Environ. Health Perspect [online]. Available: http://ehp.niehs.nih.gov/docs/2006/9058/abstract.html [accessed Aug. 21, 2006].
84. IARC (International Agency for Research on Cancer). 2005. European Prospective Investigation into Cancer and Nutrition. International Agency for Research on Cancer, World Health Organization, Lyon, France [online]. Available: http://www.iarc.fr/epic/Supdefault.html [accessed Sept. 26, 2005].
85. ILSI (International Life Science Institute). 2005. Fact Sheet: ILSI Health and Environmental Science Institute, Technical Committee on Integration of Biomonitoring Exposure Data into the Risk Assessment Process [online]. Available: http://www.hesiglobal.org/NR/ rdonlyres/078BC618-01B1-41F9-814F-E36580F19449/0/IntegrationofBiomonitoringEx posureData.pdf [accessed April 19, 2006].
86. ISBER (International Society for Biological and Environmental Repositories). 2005. About ISBER. International Society for Biological and Environmental Repositories, Bethesda, MD [online]. Available: http://www.isber.org/aboutisber.html [accessed April 14, 2006].
87. Jakubowski, M. 2004. Biological monitoring of environmental exposure to lead-an example from Poland. Presentation at the Session on Biomonitoring, The European Environment and Health Action Plan 2004-2010: Implementation, December 2-3, 2004, Egmond aan Zee, The Netherlands.
88. Jakubowski, M., and M. Trzcinka-Ochocka. 2005. Biological monitoring of exposure: Trends and key developments. J. Occup. Health 47(1):22-48.
89. Karmaus. W., S. Huang, and L. Cameron. 2002. Parental concentration of dichlorodiphenyl dichloroethene and polychlorinated biphenyls in Michigan fish eaters and sex ratio in offspring. J. Occup. Environ. Med. 44(1):8-13.
90. Kimmel, C.A., G.W. Collman, N. Fields, and B. Eskenazi. 2005. Lessons learned for the National Children's Study from the National Institute of Environmental Health Sciences/ U.S. Environmental Protection Agency Centers for Children's Environmental Health and Disease Prevention Research. Environ. Health. Perspect. 113(10):1414-1418.
91. Knudsen, L.E. 2004. Workplace genetic screening. In Practical Ethics in Occupational Health P. Westerholm, J. Ovretveit, and T. Nilstun, eds. Oxfordshire, UK: Radcliff Medical Press (as cited in ECOTOC 2005).
92. Landrigan, P.J., and G. Tamburlini. 2005. Children's health and the environment: A transatlantic dialogue. Environ. Health Perspect. 113(10):A646-A647.
93. Lee, L.W., J. Griffith, H. Zenick, and B.S. Hulka. 1995. Human tissue monitoring and specimen banking: Opportunities for exposure assessment, risk assessment, and epidemiologic research. Environ. Health Perspect. 103(Suppl. 3):3-8.
94. Litt, J., N. Tran, K.C. Malecki, R. Neff, B. Resnick, and T. Burke. 2004. Identifying priority health conditions, environmental data, and infrastructure needs: A synopsis of the Pew Environmental Health Tracking Project. Environ. Health Perspect. 112(14):1414-1418.
95. Lonky, E., J. Reihman, T. Darvill, J. Mather, Sr., and H. Daly. 1996. Neonatal behavioral assessment scale performance in humans influenced by maternal consumption of environmentally contaminated Lake Ontario fish. J. Great Lakes Res. 22(2):198-212.
96. LRI (Long-Range Research Initiative). 2001. Goals and Principles to Govern the Long-Range Research Initiative [online]. Available: http://www.uslri.com/about.cfm?id=about [accessed June 3, 2005].
97. LRI (Long-Range Research Initiative). 2005. Global Research Strategy [online]. Available: http://www.uslri.com/documents/cat_1/doc_276.pdf [accessed June 3, 2005].
98. NBAC (National Bioethics Advisory Committee). 1999. Research Involving Human Biological Materials: Ethical Issues and Policy Guidance, Vol. 1. Report and Recommendations of the National Bioethics Advisory Commission. Rockville, MD: National Bioethics Advisory Commission.
99. NCHS (National Center for Health Statistics). 1985. Plan and Operation for the Hispanic Health and Nutrition Examination Survey 1982-84. Vital and Health Statistics Series 1, No. 19. DHHS (PHS) 85-1321. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, Hyatts ville, MD. September 1985 [online]. Available: http://www.cdc.gov/nchs/data/series/sr_ 01/sr01_019.pdf [accessed June 3, 2005].
100. NCHS (National Center for Health Statistics). 2005. NHANES Stored Biologic Specimens.
101. National Health and Nutrition Examination Survey. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, MD [online]. Available: http://www.cdc.gov/nchs/about/major/ nhanes/serum1b.htm [accessed Sept. 26, 2005].
102. Needham, L.L. 2005. Biomonitoring in NHANES and Other Programs. Presented at the Second Meeting on Human Biomonitoring for Environmental Toxicants, April 28, 2005, Washington, DC.
103. Needham, L.L., D.B. Barr, and A.M. Calafat. 2005a. Characterizing children's exposures: Beyond NHANES. Neurotoxicology 26(4):547-553.
104. Needham, L.L. , H. özkaynak, R.M. Whyatt, D.B. Barr, R.Y. Wang, L. Naeher, G. Akland, T. Bahadori, A. Bradman, R. Fortmann, L.J. Liu, M. Morandi, M.K. O'Rourke, K. Thomas, J. Quackenboss, P.B. Ryan, and V. Zartarian. 2005b. Exposure assessment in the National Children's Study: Introduction. Environ. Health Perspect. 113(8):1076- 1082.
105. Neri, M., D. Ugolini, S. Bonassi, A. Fucic, N. Holland, L.E. Knudsen, R.J. Sram, M. Ceppi, V. Bocchini, and D.F. Merlo. 2006. Children's exposure to environmental pollutants and biomarkers of genetic damage. II. Results of a comprehensive literature search and metaanalysis. Mutat. Res. 612(1):14-39.
106. NIEHS (National Institute of Environmental Health Sciences). 2005. NIEHS Superfund Basic Research Program. U.S. Department of Health and Human Services, National Institute of Health, National Institute of Environmental Health Sciences [online]. Available: http:// www-apps.niehs.nih.gov/sbrp/index.cfm [accessed June 3, 2005].
107. NIOSH (National Institute for Occupational Safety and Health). 2005. NIOSH Safety and Health Topic: Adult Blood Lead Epidemiology and Surveillance (ABLES). National Institute for Occupational Safety and Health [online]. Available: http://www.cdc.gov/niosh/ topics/ABLES/ables.html. [accessed Dec. 22, 2005].
108. NRC (National Research Council). 1991. Monitoring Human Tissues for Toxic Substances. Washington, DC: National Academy Press.
109. OSHA (Occupational Safety and Health Administration). 2005. Blood Lead Laboratories Program Descriptions and Background. Salt Lake Technical Center (SLTC), U.S. Department of Labor, Occupational Safety and Health Administration [online]. Salt Lake Technical Center (SLTC), U.S. Department of Labor, Occupational Safety and Health Administration [online]. Available: http://www.osha.gov/SLTC/bloodlead/program.html [accessed Dec. 22, 2005].
110. Persky, V., M. Turyk, H.A. Anderson, L.P. Hanrahan, C. Falk, D.N. Steenport, R. Chatterton, Jr., and S. Freels. 2001. The effects of PCB exposure and fish consumption on endogenous hormones. Great Lakes Consortium. Environ. Health Perspect. 109(12):1275- 1283.
111. Pirkle, J.L. 2005. Telebriefing Transcript Third National Report on Human Exposure to Environmental Chemicals. Media Relations. Centers for Disease Control and Prevention July 21, 2005 [online]. Available: http://www.cdc.gov/od/oc/media/transcripts/t050721.htm [accessed April 18, 2006].
112. Reis, M.F., C. Sampaio, M. Melim, and J.P. Miguel. 2004. Environmental Health Survey Programs (ProVEpAs) in Portugal. Presentation at the Session on Biomonitoring, The European Environment and Health Action Plan 2004-2010: Implementation, December 2-3, 2004, Egmond aan Zee, The Netherlands.
113. Robison, S.H., and D.B. Barr. In press. Use of biomonitoring data to evaluate methyl eugenol exposure and its relationship to the environmental public health continuum. Environ. Health Perspect [online]. http://ehp.niehs.nih.gov/docs/2006/9057/abstract.html [accessed Aug. 21, 2006].
114. Schantz, S.L., J.C. Gardiner, D.M. Gasior, A.M. Sweeney, H.E. Humphrey, and R.J. McCaffrey. 1999. Motor functioning in aging Great Lakes fisheaters. Environ. Res. 80(2 Pt 2):S46-S56.
115. Schantz, S.L., D.M. Gasior, E. Polverejan, R.J. McCaffrey, A.M. Sweeney, H.E. Humphrey, and J.C. Gardiner. 2001. Impairments if memory and learning in older adults exposed to polychlorinated biphenyls via consumption of Great Lakes fish. Environ. Health Perspect. 109(6):605-611.
116. Schober, S. 2005. National Health and Nutrition Examination Survey (NHANES): Environmental Biomonitoring Measures, Interpretation of Results. Presented at the Second Meeting on Human Biomonitoring for Environmental Toxicants, April 28, 2005, Washington, DC.
117. Sexton, K., L.L. Needham, and J.L. Pirkle. 2004. Human biomonitoring of environmental chemicals: Measuring chemicals in human tissue is the "gold standard" for assessing the people's exposure to pollution. Am. Sci. 92(1):39-45.
118. Statistics Canada. 2006. Canadian Health Measures Survey [online]. Available: http://www.statcan.ca/english/survey/household/measures/measures.htm [accessed April 11, 2006].
119. Stewart, P., J. Reihman, E. Lonky, T.J. Darvill, and J. Pagano. 2000. Prenatal PCB exposure and neonatal behavioral assessment scale (NBAS) performance. Neurotoxicol. Teratol. 22(1):21-29.
120. Stewart, P.W., J. Reihman, E.I. Lonky, T.J. Darvill, and J. Pagano. 2003. Cognitive development in preschool children prenatally exposed to PCBs and MeHg. Neurotoxicol. Teratol. 25(1):11-22.
121. Trasande, L., and P.J. Landrigan. 2004. The National Children's Study: A critical national investment. Environ. Health. Perspect. 112(14):A789-A790.
122. Utah Department of Health. 2006. Environmental Public Health Tracking: Biomonitoring. Utah Department of Health, Office of Epidemiology [online]. Available: http://health.utah.gov/els/epidemiology/envepi/activities/EPHTP/ephtb.htm [accessed Jan. 18, 2006].
123. University of Copenhagen. 2005. ChildrenGenoNetwork, Background. Institute of Public Health, University of Copenhagen [online]. Available: http://cgn.pubhealth.ku.dk/child rengeno_en/background/ [accessed Sept. 26, 2005].
124. WHO (World Health Organization). 2000. Interlaboratory Quality Assessment on Levels of PCBs, PCDDs, and PCDFs in Human Milk and Blood Plasma: Fourth Round of WHOcoordinated study. EUR/00/5020352, E70039. WHO European Centre for Environment and Health, Bilthoven [online]. Available: http://www.who.dk/document/e70039.pdf [accessed Nov. 23, 2005].
125. WHO (World Health Organization). 2005. Biomonitoring of Human Milk for Persistent Organic Pollutants (POP). World Health Organization [online]. Available: http://www.who.int/foodsafety/chem/pops/en/ [accessed Dec. 20, 2005].
126. WWF (World Wildlife Fund). 2003. Contamination: The Results of WWF's Biomonitoring Survey. WWF-UK. November 2003 [online]. Available: http://www.wwf.org.uk/file library/pdf/biomonitoringresults.pdf [accessed April 17, 2006].
127. WWF (World Wildlife Fund). 2004. Bad Blood? A Survey of Chemicals in the Blood of European Ministers. World Wildlife Fund [online]. Available: http://assets.panda.org/ downloads/badbloodoctober2004.pdf [accessed April 17, 2006].
128. Zenick, H., and J. Griffith. 1995. The role of specimen banking in risk assessment. Environ. Health Perspect. 103(Suppl. 3):9-12.
129. Bernard, A., and R. Lauwerys. 1986. Present status and trends in biological monitoring of exposure to industrial chemicals. J. Occup. Med. 28(8):558-562.
130. Birnbaum, L.S., and D.F. Staskal. 2004. Brominated flame retardants: Cause for concern? Environ Health Perspect. 112(1):9-17.
131. Broussard, L.A., T. Brustowicz, T. Pittman, K.D. Atkins, and L. Presley. 1997. Two traffic fatalities related to the use of difluoroethane. J. Forensic Sci. 42(6):1186-1187.
132. Broussard, L.A., A.K. Broussard, T.S. Pittman, and D.K. Lirette. 2000. Death due to inhalation of ethyl chloride. J Forensic Sci. 45(1):223-225.
133. Burke, T., H. Anderson, N. Beach, S. Colome, R.T. Drew, M. Firestone, F.S. Hauchman, T.O. Miller, D.K. Wagener, L. Zeise, and N. Tran. 1992. Role of exposure databases in risk management. Arch. Environ. Health 47(6):421-429.
134. CDC (Centers for Disease Control and Prevention). 2005. Third National Report on Human Exposure to Environmental Chemicals. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http:// www.cdc.gov/exposurereport/3rd/pdf/thirdreport.pdf [accessed Sept. 26, 2005].
135. Dor, F., W. Dab, P. Empereur-Bissonnet, and D. Zmirou. 1999. Validity of biomarkers in environmental health studies: The case of PAHs and benzene. Crit. Rev. Toxicol. 29(2): 129-168.
136. Jackson, R. 2005. Biomonitoring. Presentation at the Fourth Meeting on Human Biomonitoring of Environmental Toxicants, October 27, 2005, Irvine, CA.
137. Krimsky, S. 2005. The weight of scientific evidence in policy and law. Am. J. Public Health 95(Suppl. 1):S129-S136.
138. NRC (National Research Council). 1991. Monitoring Human Tissues for Toxic Substances. Washington, DC: National Academy Press.
139. Perbellini, L., N. Veronese, and A. Princivalle. 2002. Mercapturic acids in the biological monitoring of occupational exposure to chemicals. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 781(1-2):269-290.
140. Pirkle, J.L., L.L. Needham, and K. Sexton. 1995. Improving exposure assessment by monitoring human tissues for toxic chemicals. J. Expo. Anal. Environ. Epidemiol. 5(3):405-424.
141. Rubin, C., E. Esteban, R.H. Hill, Jr., and K. Pearce. 2002. Introduction-the methyl parathion story: A chronicle of misuse and preventable human exposure. Environ. Health Perspect. 110(Suppl. 6):1037-1040.
142. Schulte, P.A., and G. Talaska. 1995. Validity criteria for the use of biological markers of exposure to chemical agents in environmental epidemiology. Toxicology 101(1-2):73-88.
143. Sexton, K., L.L. Needham, and J.L. Pirkle. 2004. Human biomonitoring of environmental chemicals: Measuring chemicals in human tissue is the "gold standard" for assessing the people's exposure to pollution. Am. Sci. 92(1):39-45.
144. Sharma, R.A., and P.B. Farmer. 2004. Biological relevance of adduct detection to the chemoprevention of cancer. Clin. Cancer Res. 10(15):4901-4912.
145. Sinks, T. 2005. Future Opportunities for Biomonitoring at CDC? Where we are and ? Where we go? Presentation at the Fourth Meeting on Human Biomonitoring of Environmental Toxicants, October 27, 2005, Irvine, CA.
146. Swan, S.H., K.M. Main, F. Liu, S.L. Stewart, R.L. Kruse, A.M. Calafat, C.S. Mao, J.B. Redmon, C.L. Ternand, S. Sullivan, and J.L. Teague. 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 113(8):1056-1061.
147. Thornton, J.W., M. McCally, and J. Houlihan. 2002. Biomonitoring of industrial pollutants: Health and policy implications of the chemical body burden. Public Health Reports 117(4):315-323.
148. WHO (World Health Organization). 2001. Biomarkers in Risk Assessment: Validity and Validation. Environmental Health Criteria 222. Geneva: World Health Organization [online]. Available: http://www.inchem.org/documents/ehc/ehc/ehc222.htm [accessed Dec.1, 2005].
149. ACGIH (American Conference of Governmental Industrial Hygienists). 1995. Topics in Biological Monitoring: A Compendium of Essays. Cincinnati, OH: American Conference of Governmental Industrial Hygienists.
150. Adler, P.S. 2002. Science, politics, and problem solving: Principles and practices for the resolution of environmental disputes in the midst of advancing technology, uncertain or changing science, and volatile public perceptions. Penn. St. Environ. Law Rev. 10(2):323- 343.
151. Andrews, C.J. 2002. Humble Analysis: The Practice of Joint Fact-Finding. Westport, CT: Praeger.
152. Balch, G.I., and S.M. Sutton. 1995. Putting the first audience first: Conducting useful evaluation for a risk-related government agency. Risk Anal. 15(2):163-168.
153. Barr, D.B., R.Y. Wang, and L.L. Needham. 2005a. Biologic monitoring of exposure to environmental chemicals throughout the life stages: Requirements and issues for consideration for the National Children's Study. Environ. Health Perspect. 113(8):1083-1091.
154. Barr, D.B., L.C. Wilder, S.P. Caudill, A.J. Gonzalez, L.L. Needham, and J.L. Pirkle. 2005b. Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. Environ. Health Perspect. 113(2):192-200.
155. Beecher, N., E. Harrison, N. Goldstein, M. McDaniel, P. Field, and L. Susskind. 2005. Risk perception, risk communication, and stakeholder involvement for biosolids management and research. J. Environ. Qual. 34(1):122-128.
156. Bernard, A.M. 1995. Biokinetics and stability aspects of biomarkers: Recommendations for application in population studies. Toxicology 101(1-2):65-71.
157. Bernard, A.B. and R. Lauwerys. 1986. Present status and trends in biological monitoring of exposure to industrial chemicals. J. Occup. Med. 28(8):558-562.
158. Bernard, A., and R. Lauwerys. 1987. General principles for biological monitoring of exposure to chemicals. Pp. 1-16 in Biological Monitoring of Exposure to Chemicals: Organic Compounds, M.H. Ho, and H.K. Dillon, eds. New York: Wiley.
159. Butchko, H.H., W.W. Stargel, C.P. Comer, D.A. Mayhew, C. Benninger, G.L. Blackburn, L.M. de Sonneville, R.S. Geha, Z. Hertelendy, A. Koestner, A.S. Leon, G.U. Liepa, K.E. Mc- Martin, C.L. Mendenhall, I.C. Munro, E.J. Novotny, A.G. Renwick, S.S. Schiffman, D.L. Schomer, B.A. Shaywitz, P.A. Spiers, T.R. Tephly, J.A. Thomas, and F.K. Trefz. 2002. Aspartame: Review of safety [review]. Regul. Toxicol. Pharmacol. 35(2 Pt 2):S1-S93.
160. Comfort, L.K. 1985. Action research: A model for organizational learning. J. Pol. Anal. Manage. 5:100-118.
161. Daston, G., E. Faustman, G. Ginsberg, P. Fenner-Crisp, S. Olin, B. Sonawane, J. Bruckner, W. Breslin, and T.J. McLaughlin. 2004. A framework for assessing risks to children from exposure to environmental agents. Environ. Health Perspect. 112(2):238-256.
162. Droz, P.O., and J.G. Fernandez. 1977. Effect of physical workload on retention and metabolism of inhaled organic solvents. A comparative theoretical approach and its applications with regards to exposure monitoring. Int. Arch. Occup. Environ. Health. 38(4):231- 246.
163. European Commission. 2004. Baseline Report on "Biomonitoring for Children" in the Framework of the European Environment and Health Strategy (COM(2003)338 final). Prepared by the Technical Working Group on Integrated Monitoring. January 9, 2004 [online]. Available: http://www.brussels-conference.org/Download/baseline_report/BR_ Biomonitoring_final.pdf [accessed June 3, 2005].
164. ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals). 2005. Guidance for the Interpretation of Biomonitoring Data. Document No. 44. Brussels, Belgium: ECOTOC.
165. Ehrmann, J.R., and B.L. Stinson. 1999. Joint fact-finding and the use of technical experts. Pp. 375-400 in The Consensus Building Handbook: A Comprehensive Guide to Reaching Agreement, L. Susskind, S. McKearnan, and J. Thomas-Larmer, eds. Thousand Oaks, CA: Sage.
166. EPA (U.S. Environmental Protection Agency). 2002. Community, Culture and the Environment: A Guide to Understanding a Sense of Place. EPA 842-B-01-003. Office of Water, U.S. Environmental Protection Agency, Washington, DC [online]. Available: http:// www.epa.gov/ecocommunity/pdf/ccecomplete.pdf [accessed Dec. 1, 2005].
167. Eskenazi, B., A. Bradman, E.A. Gladstone, S. Jaramillo, K. Birch, and N.T. Holland. 2003. CHAMACOS, A longitudinal birth cohort study: Lessons from the fields. J. Child. Health 1(1):3-27.
168. Eskenazi, B., E. Gladstone, G. Berkowitz, C. Drew, E. Faustman, N.T. Holland, S. Lanphear, S. Meilsel, F. Perera, V. Rauh, A. Sweeney, R. Whyatt, and K. Yolton. 2005. Methodologic and logistic issues in conducting longitudinal birth cohort studies: Lessons learned from the Center of Children's Environmental Health and Disease Prevention Research. Environ. Health Perspect. 113(10):1419-1429.
169. Fairchild, A.L., and R. Bayer. 2004. Ethics and the conduct of public health surveillance. Science 303(5658):631-632.
170. Fisher, A., M.T. Pavlova, and V.T. Covello, eds. 1991. Evaluation and Effective Risk Communications: Workshop proceedings. EPA/600/9-90/054. Interagency Task Force on Environmental Cancer and Heart and Lung Disease, Center for Environmental Research Information. U.S. Environmental Protection Agency, Washington, DC.
171. Flesch-Janys, D., H. Becher, P. Gurn, D. Jung, J. Konietzko, A. Manz, and O. Papke. 1996. Elimination of polychlorinated dibenzodioxins and dibenzofurans in occupationally exposed persons. J. Toxicol. Environ. Health Part A 47(4):363-378.
172. Ginsberg, G., D. Hattis, and B. Sonawane. 2004. Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants. Toxicol. Appl. Pharmacol. 198(2):164-183.
173. Goodman, G.E., M.D. Thornquist, C. Edelstein, and G.S. Omenn. 2006. Biorepositories: Let's not lose what we have so carefully gathered! Cancer Epidemiol. Biomarkers Prev. 15(4):599-601.
174. Grill, K., and S.O. Hansson. 2005. Epistemic paternalism in public health. J. Med. Ethics 31(11):648-653.
175. Gunter, E.W. 1997. Biological and environmental specimen banking at the Centers for Disease and Control and Prevention. Chemosphere 34(9/10):1945-1953.
176. Hauser, R., J.D. Meeker, S. Park, M.J. Silva, and A.M. Calafat. 2004. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ. Health Persp. 112(17):1734-1740.
177. Heinrich-Rumm, R., G. Lehnert, and J. Angerer. 1996. The German external quality assessment scheme in occupational and environmental medicine. Ann. Ist. Super Sanita. 32(2):2 47-251.
178. Holland, N.T., M.T. Smith, B. Eskenazi, and M. Bastaki. 2003. Biological sample collection and processing for molecular epidemiological studies. Mutat. Res. 543 (3):217-234.
179. Holland, N.T., L. Pfleger, E. Berger, A. Ho, and M. Bastaki. 2005. Molecular epidemiology biomarkers: Sample collection and processing considerations. Toxicol. Appl. Pharmacol. 206(2):261-268.
180. IOM (Institute of Medicine). 1999. Toward Environmental Justice: Research, Education, and Health Policy Needs. Washington, DC: National Academy Press.
181. ISBER (International Society for Biological and Environmental Repositories). 2005. Best practices for repositories I: Collection, storage, and retrieval of human biological materials for research. CPT 3(1):5-48.
182. Jonsson F., and G. Johanson. 2001. A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane. Toxicol. Appl. Pharmacol. 174(2):99-112.
183. Kaneko, A., J.K. Lum, L. Yaviong, N. Takahashi, T. Ishizaki, L. Bertilsson, T. Kobayakawa, and A. Bjorkman. 1999. High and variable frequencies of CYP2C19 mutations: Medical consequences of poor drug metabolism in Vanuatu and other Pacific islands. Pharmacogenetics 9(5):581-590.
184. Kass, N.E. 2005. Research Ethics and Human Biomonitoring Research. Presentation at the Second Meeting on Human Biomonitoring of Environmental Toxicants, April 28, 2005, Washington, DC.
185. Kemmeren, J.M., G. van Poppel, P. Verhoef, and M.J. Jarvis. 1994. Plasma cotinine: Stability in smokers and validation of self-reported smoke exposure in nonsmokers. Environ. Res. 66(2):235-243.
186. Fenske. 2005. Comparison of organophosphorous pesticide metabolite levels in single and multiple daily urine samples collected from preschool children in Washington State. J. Expo. Anal. Environ. Epidemiol. 15(2):164-171.
187. Landi, M.T., and N. Caporaso. 1997. Sample collection, processing and storage. Pp. 223-236 in Application of Biomarkers in Cancer Epidemiology, P. Toniolo, P. Boffetta, and D.E.G. Shuker, eds. IARC Scientific Publications 142. Lyon: IARC.
188. Lasker, R.D., and E.S. Weiss. 2003. Broadening participation in community problem-solving: A multidisciplinary model to support collaborative practice and research. J. Urban Health 80(1):14-60.
189. Liira, J., G. Johanson, and V. Riihimäki. 1990. Dose-dependent kinetics of inhaled methyl ethyl ketone in man. Toxicol. Lett. 50(2-3):195-201.
190. Lof, A., A. Johanson, M. Rannug, and M. Warholm. 2000. Glutathione transferase T1 phenotype affects the toxicokinetics of inhaled methyl chloride in human volunteers. Pharmacogenetics 10(7):645-653.
191. Lu, C., R. Bravo, L.M. Caltabiano, R.M. Irish, G. Weersekera, and D.B. Barr. 2005. The presence of dialkylphosphates in fresh fruit juices: Implications for organophosphorus pesticide exposure and risk assessments. J. Toxicol. Environ. Health A 68(3):209-227.
192. Marmot, M.G., G.D. Smith, S. Stansfeld, C. Patel, F. North, J. Head, I. White, E. Brunner, and A. Feeney. 1991. Health inequalities among British civil servants: The Whitehall II study. Lancet 337(8754):1378-1393.
193. Metcalf, S.W., and K.G. Orloff. 2004. Biomarkers of exposure in community settings. J. Toxicol. Environ. Health Part A 67(8-9):715-726.
194. Mizutani, T. 2003. PM frequencies of major CYPs in Asians and Caucasians. Drug Metab. Rev. 35(2-3):99-106.
195. Nebert, D.W. 2000. Suggestions for the nomenclature of human alleles: Relevance to ecogenetics, pharmacogenetics and molecular epidemiology. Pharmacogenetics 10(4): 279-290.
196. Needham, L.L., and R.Y. Wang. 2002. Analytic considerations for measuring environmental chemicals in breast milk. Environ Health Perspect. 110(6):A317-A324.
197. Needham, L.L., H. Ozkaynak, R.M. Whyatt, D.B. Barr, R.Y. Wang, L. Naeher, G. Akland, T. Bahadori, A. Bradman, R. Fortmann, L.J. Liu, M. Morandi, M.K. O'Rourke, K. Thomas, J. Quackenboss, P.B. Ryan, and V. Zartarian. 2005. Exposure assessment in the national Children's Study: Introduction. Environ. Health Perspect. 113(8):1076- 1082.
198. Nihlén, A., and G. Johanson. 1999. Physiologically based toxicokinetic modeling of inhaled ethyl tertiary-butyl ether in humans. Toxicol. Sci. 51(2):184-194.
199. NRC (National Research Council). 1987. Biologic markers in environmental health research. Environ Health Perspect. 74:3-9.
200. NRC (National Research Council). 1991. Monitoring Human Tissues for Toxic Substances. Washington, DC: National Academy Press.
201. NRC (National Research Council). 1993. Pesticides in the Diets of Infants and Children. Washington, DC: National Academies Press.
202. özkaynak, H., R.M. Whyatt, L.L. Needham, G. Akland, and J. Quackenboss. 2005. Exposure assessment implications for the design and implementation of the National Children's Study. Environ. Health Perspect. 113(8):1108-1115.
203. Pflugh, K.K., J.A. Shaw, and B.B. Johnson. 1994. Establishing Dialogue: Planning for Successful Environmental Management; A Guide to Effective Communication Planning. Trenton, NJ: New Jersey Department of Environmental Protection and Energy.
204. Risk Policy Report. 2001. Chemicals in breast milk could act as indicator, shape regulatory policy. Inside EPA's-Risk Policy Report 8(2):24-26.
205. Rivers, P.A., A. Dobalian, and F.A. Germinario. 2005. A review and analysis of the clinical laboratory improvement amendment of 1988: Compliance plans and enforcement policies. Health Care Manage Rev. 30(2):93-102.
206. Rohrmann, B. 1992. The evaluation of risk communication effectiveness. Acta Psychol. 81(2):169-192.
207. Rohrmann, B. 2000. A socio-psychological model for analyzing risk communication processes. Australasian J. Disaster Trauma Studies [online]. Available: http://www.massey.ac.nz/~trauma/issues/2000-2/rohrmann.htm [accessed April 21, 2006].
208. Santos, S.L., and C. Chess. 2003. Evaluating citizen advisory boards: The importance of theory and participant-based criteria and practical implications. Risk Anal. 23(2):269- 280.
209. Schulte, P.A. 2005. Application and Design Issues in Human Biomonitoring. Presentation at the Second Meeting on Human Biomonitoring of Environmental Toxicants, April 28, 2005, Washington, DC.
210. Schulte, P.A., and M.H. Sweeney. 1995. Ethical considerations, confidentiality issues, rights of human subjects, and uses of monitoring data in research and regulation. Environ. Health Perspect. 103(suppl. 3):69-74.
211. Schulte, P.A., and G. Talaska. 1995. Validity criteria for the use of biological markers of exposure to chemical agents in environmental epidemiology. Toxicology 101(1-2): 73-88.
212. Schulte, P.A., D. Hunter, and N. Rothman. 1997. Ethical and social issues in the use of biomarkers in epidemiological research. IARC Sci Publ. (142):313-318.
213. Silva, M.J., D.B. Barr, J.A. Reidy, N.A. Malek, C.C. Hodge, S.P. Caudill, J.W. Brock, L.L. Needham, and A.M. Calafat. 2004. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Study (NHANES) 1999-2000. Environ. Health Perspect. 112(3): 331-338.
214. Soskolne, C.L. 1997. Ethical, social, and legal issues surrounding studies of susceptible populations and individuals. Environ. Health Perspect. 105(suppl. 4):837-841.
215. Stern, P.C., and H.V. Fineberg, eds. 1996. Understanding Risk: Informing Decisions in a Democratic Society. Washington, DC: National Academy Press.
216. Stinson, B.L., and J.R. Ehrmann. 1998. Joint fact-finding in consensus-building processes. Inside EPA's-Risk Policy Report 5(11):36-38.
217. Thompson, K.M., and D.L. Bloom. 2000. Communication of risk assessment information to risk managers. J. Risk Res. 3(4):333-352.
218. Tinker, T. 1994. Case Studies of Applied Evaluation for Health Risk Communication: Workshop Proceedings, June 9, Annapolis, MD. U.S. Department of Health and Human Services, Washington, DC.
219. Veach, P.M., D.M. Bartels, and B.S. LeRoy. 2001. Ethical and professional challenges posed by patients with genetic concerns: A report of focus group discussions with genetic counselors, physicians, and nurses. J. Genet. Couns. 10(2):97-119.
220. Warholm, M., A.K. Alexandrie, J. Hogberg, K. Sigvardsson, A. Rannug. 1994. Polymorphic distribution or glutathione transferase activity with methyl chloride in human blood. Pharmacogenetics 4(6):307-311.
221. Webler, T. 1998. Beyond science: Deliberation and analysis in public decision making. Human Ecol. Rev. 5(1):61-64.
222. Weinstein, N.D., and P.M. Sandman. 1993. Some criteria for evaluating risk messages. Risk Anal. 13(1):103-114.
223. Wessels, D., D.B. Barr, and P. Mendola. 2003. Use of biomarkers to indicate exposure of children to organophosphate pesticides: Implications for a longitudinal study of children's environmental health. Environ. Health Perspect. 111(16):1939-1946.
224. Winn, D.M., M.E. Reichman, and E. Gunter. 1990. Epidemiologic issues in the design and use of biologic specimen banks. Epidemiol. Rev. 12:56-70.
225. ACGIH (American Conference of Governmental Industrial Hygienists). 2003. TLVs and BEIs: Threshold Limit Values for Chemical Substances and Biological Exposure Indices. American Conference of Governmental Industrial Hygienists, Cincinnati, OH.
226. ACGIH (American Conference of Governmental Industrial Hygienists). 2005. TLVs and BEIs: Based on the Documentation of the Threshold Limit Values for Chemical Substances and Physical Agents & Biological Exposure Indices. American Conference of Governmental Industrial Hygienists, Cincinnati, OH.
227. Baghurst, P.A., A.J. McMichael, N.R. Wigg, G.V. Vimpani, E.F. Robertson, R.J. Roberts, and S.L. Tong. 1992. Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie cohort study. N. Engl. J. Med. 327(18):1279-1284.
228. Barr, D.B., L.C. Wilder, S.P. Caudill, A.J. Gonzalez, L.L. Needham, and J.L. Pirkle. 2005. Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. Environ. Health Perspect. 113(2):192-200.
229. Bellinger, D.C., and H.L. Needleman. 2003. Intellectual impairment and blood lead levels. N. Engl. J. Med. 349(5):500-502.
230. Bellinger, D.C., K.M. Stiles, and H.L. Needleman. 1992. Low level lead exposure, intelligence and academic achievement: A long-term follow-up study. Pediatrics 90(6):855-861.
231. Birnbaum, L.S., and D.F. Staskal. 2004. Brominated flame retardants: Cause for concern? Environ. Health Perspect. 112(1):9-17.
232. Blount, B.C., M.J. Silva, S.P. Caudill, L.L. Needham, J.L. Pirkle, E.J. Sampson, G.W. Lucier, R.J. Jackson, and J.W. Brock. 2000. Levels of seven urinary phthalate metabolites in a human reference population. Environ. Health Perspect. 108(10):979-982.
233. Bonassi, S., and W.W. Au. 2002. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat. Res. 511(1):73-86.
234. Bradman, A., B. Eskenazi, D.B. Barr, R. Bravo, R. Castorina, J.U. Chevrier, K. Kogut, M.E. Harnly, and T.E. McKone. 2005. Organophosphate urinary metabolite levels during pregnancy and after delivery in women living in an agricultural community. Environ. Health Perspect. 113(12):1802-1807.
235. Buchanan, J.R., L.T. Burka, and R.L. Melnick. 1997. Purpose and guidelines for toxicokinetic studies within the National Toxicology Program. Environ. Health Perspect. 105(5):468-471.
236. Calleman, C.J. 1996. The metabolism and pharmacokinetics of acrylamide: Implications for mechanisms of toxicity and human risk estimation. Drug Metab. Rev. 28(4): 527-590.
237. Canfield, R.L., C.R. Henderson, D.A. Cory-Slechta, C. Cox, T.A. Jusko, and B.P. Lanphear. 2003. Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter. N. Engl. J. Med. 348(16):1517-1526.
238. Canuel, G., C. Viau, and K. Krishnan. 2000. A modeling framework for back-calculating ambient concentrations of volatile organic chemicals from biomarker data. Pp. 97-102 in Proceedings of the International Conference on Health Sciences Simulation, J.G. Anderseon, and M. Katzper, eds. San Diego, CA: Society for Computer Simulation International.
239. Castorina, R., A. Bradman, T.E. McKone, D.B. Barr, M.E. Harnley, and B. Eskenazi. 2003. Cumulative organophosphate pesticide exposure and risk assessment among pregnant women living in an agricultural community: A case study from the CHAMACOS cohort. Environ. Health Perspect. 111(13):1640-1648.
240. CDC (Centers for Disease Control and Prevention). 1991. Preventing Lead Poisoning in Young Children: A Statement by the Centers for Disease Control. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http://aepo-xdv-www.epo.cdc.gov/wonder/prevguid/p0000029/ p0000029.asp [accessed Jan. 19, 2006].
241. CDC (Centers for Disease Control and Prevention). 2001. National Report on Human Exposure to Environmental Chemicals. National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
242. CDC (Centers for Disease Control and Prevention). 2003. Second National Report on Human Exposure to Environmental Chemicals. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http://www.jhsph.edu/ephtcenter/Second%20Report.pdf [accessed Nov. 16, 2005].
243. CDC (Centers for Disease Control and Prevention). 2005. Third National Report on Human Exposure to Environmental Chemicals. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http:// www.cdc.gov/exposurereport/3rd/ [accessed Nov. 16, 2005].
244. CERHR (Center for the Evaluation of Risks to Human Reproduction). 2000. NTP-CERHR Expert Panel Report on Di-2-ethylhexylphthalate. NTP-CERHR-DINP-00. National Toxicology Program, U.S. Department of Health and Human Services, Research Triangle Park, NC. October, 2000.
245. Cooney, G.H., A. Bell, W. McBride, and C. Carter. 1989. Low-level exposures to lead: The Sydney lead study. Dev. Med. Child. Neurol. 31(5):640-649.
246. David, R.M. 2000. Exposure to phthalate esters [letter]. Environ. Health Perspect. 108(10): 440.
247. DFG (Deutsche Forschungsgemeinschaft). 2004. List of MAK- and BAT-Values 2004, 1st Ed. Report No. 40. Weinheim: Wiley-VCH.
248. Dietrich, K.N., O.G. Berger, P.A. Succop, P.B. Hammond, and P.L. Bornschein. 1993. The developmental consequences of low to moderate prenatal and postnatal lead exposure: Intellectual attainment in the Cincinnati lead study cohort following school entry. Neurotoxicol Teratol 15(1):37-44.
249. Dvorchik, B.H., and E.S. Vesell. 1976. Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring. Clin. Chem. 22(6):868-878.
250. Eaton, D.L. 2000. Biotransformation enzyme polymorphisms and pesticide susceptibility. Neurotoxicology 21(1-2):101-111.
251. Emond, E., M. Charbonneau, and K. Krishnan. 2005a. Physiologically based modeling of the accumulation in plasma and tissue lipids of a mixture of PCB congeners in female Sprague-Dawley rats. J. Toxicol. Environ. Health A 68(16):1393-1412.
252. Emond, C, J.E. Michalek, L.S. Birnbaum, and M.J. DeVito. 2005b. Comparison of the use of a physiologically based pharmacokinetic model and a classical pharmacokinetic model for dioxin exposure assessment. Environ. Health Perspect. 113(12):1666-1668.
253. EPA (U.S. Environmental Protection Agency). 1991. Di(2-ethylhexyl) phthalate (DEHP) (CASRN 117-81-7). Integrated Risk Information System, U.S. Environmental Protection Agency [online]. Available: http://cfpub.epa.gov/iris/quickview.cfm?substance:nmbr= 0014 [accessed Feb. 26, 2006].
254. EPA (U.S. Environmental Protection Agency). 1994. Guidance Manual for the Integrated Exposure Uptake Biokinetic Model for Lead in Children. EPA/540/R-93/081. Office of Emergency and Remedial Response, U.S. Environmental Protection Agency, Washington, DC.
255. EPA (U.S. Environmental Protection Agency). 2000. Summary Report of the Technical Workshop on Issues Associated with Considering Developmental Changes in Behavior and Anatomy when Assessing Exposure to Children, July 26-27, 2000, Washington, DC. EPA/630/R-00/005. Risk Assessment Forum, U.S. Environmental Protection Agency [online]. Available: http://cfpub.epa.gov/ncea/raf/recordisplay.cfm?deid=20680 [accessed Jan. 19, 2006].
256. EPA (U.S. Environmental Protection Agency). 2001. Methylmercury (MeHg) (CASRN 22967- 92-6). Integrated Risk Information System, U.S. Environmental Protection Agency [online]. Available: http://www.epa.gov/iris/subst/0073.htm [accessed Jan. 20, 2006].
257. EPA (U.S. Environmental Protection Agency). 2003. Exposure and Human Health Reassessment of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds National Academy Sciences (NAS) Review Draft, Dec, 2003 [online]. Available: http:// www.epa.gov/ncea/pdfs/dioxin/nas-review/ [accessed Jan. 20, 2006].
258. EPA (U.S. Environmental Protection Agency). 2005. Draft Risk Asssessment of the Potential Human Health Effects Associated with Exposure to Perfluorooctanoic Acid and its Salts, January 2005 [online]. Available: http://www.epa.gov/opptintr/pfoa/pfoarisk.pdf [accessed January 24, 2006].
259. Ernhart, C.B., M. Morrow-Tlucak, A.W. Wolf, D. Super, and D. Drotar. 1989. Low level lead exposure in the prenatal and early preschool periods: Intelligence prior to school entry. Neurotoxicol. Teratol. 11(2):161-170.
260. European Commission. 2004. Baseline Report on "Biomonitoring of Children." in the Framework of the European Environment and Health Stategy (COM(2003)338final). Prepared by the Technical Working Group on Integrated Monitoring, Subgroup Biomonitoring of Children. January 9, 2004 [online]. Available: http://www.eu-human biomonitoring.org/ documents/br_bio_final.pdf [accessed Jan. 20, 2006].
261. Fisher, J., D. Mahle, L. Bankston, R. Greene, and J. Gearhart. 1997. Lactational transfer of volatile chemicals in breast milk. Am. Ind. Hyg. Assoc. J. 58(6):425-431.
262. GAO (U.S. General Accounting Office). 2000. Toxic Chemicals: Long-term Coordinated Strategy Needed to Measure Exposures in Humans. GAO/HEHS-00-80. U.S. General Accounting Office, Washington, DC. May 2000 [online]. Available: http://www.gao.gov/ new.items/he00080.pdf. [accessed Nov. 16, 2005].
263. Gargas, M.L., R.J. Burgess, D.E. Voisard, G.H. Cason, and M.E. Andersen. 1989. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98(1):87-99.
264. Gentry, P.R., T.R. Covington, and H.J. Clewell. 2003. Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Regul. Toxicol. Pharmacol. 38(1):1-16.
265. Ginsberg, G.L., and B.F. Toal. 2000. Development of a single meal fish consumption advisory for methyl mercury. Risk Anal. 20(1):41-47.
266. Ginsberg, G., W. Slikker Jr., J. Bruckner, and B. Sonawane. 2004. Incorporating children's toxicokinetics into a risk framework. Environ. Health Perspect. 112(2):272-283.
267. Goldstein, B.D. 1996. Biological markers and risk assessment. Drug Metab. Rev. 28(1-2): 225-233.
268. Gray, L.E. Jr., J. Ostby, J. Furr, M. Price, D.N. Veeramachaneni, and L. Parks. 2000. Perinatal exposure to the phthalates DEHP, BBP and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation in the male rat. Toxicol. Sci. 58(2):350-365.
269. Han, X. 2003. Ammonium Perfluorooctanoate: Age Effect on the Plasma Concentration in Post-Weanling Rats Following Oral Gavage. Study No. Dupont 13267. EPA AR226- 1553. Haskell Laboratory for Health and Environmental Sciences. December 15, 2003.
270. Hauser, R. and A.M Calafat. 2005. Phthalates and human health. Occup. Environ. Med. 62(11):806-818.
271. Hauser, R., J.D. Meeker, S. Park, M.J. Silva, and A.M Calafat. 2004. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ. Health Perspect. 112(17):1734-1740.
272. Hoppin, J.A. J.W. Brock, B.J. Davis, and D.D. Baird. 2002. Reproducibility of urinary phthalate metabolites in first morning urine samples. Environ. Health Perspect. 110(5):515-518.
273. Hulka, B.S. 1991. Epidemiological studies using biological markers: Issues for epidemiologists. Cancer Epidemiol. Biomarkers Prev. 1(1):13-19.
274. Ingelman-Sundberg, M. 2005. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects, and functional diversity. Pharmacogenomics J. 5(1):6-13.
275. Jang, J.Y., P.O. Droz, and S. Kim. 2001. Biological monitoring of workers exposed to ethylbenzene and co-exposed to xylene. Int. Arch. Occup. Environ. Health 74(1):31-37.
276. Kaiser J. 2005. Panel finds no proof that phthalates harm infant reproductive system. Science 310(5747):422-423.
277. Kavlock, R., K. Boekelheide, R. Chapin, M. Cunningham, E. Faustman, P. Foster, M. Golub, R. Henderson, I. Hinberg, R. Little, J. Seed, K. Shea, S. Tabacova, R. Tyl, P. Williams, and T. Zacharewski. 2002. NTP Center for the Evaluation of Risk to Human Reproduction: Phthalates expert panel report on the reproductive and development toxicity of di(2-ehtylhexyl) phthalate. Reprod. Toxicol. 16(5):529-653.
278. Kedderis, G.L., and J.C. Lipscomb. 2001. Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment. Toxicol. Ind. Health 17(5-10):315-321.
279. Kershaw T.G., T.W. Clarkson, and P.H. Dhahir. 1980. The relationship between blood levels and dose of methylmercury in man. Arch. Environ. Health 35(1):28-36.
280. Kessova, I., and A.I. Cederbaum. 2003. CYP2E1: Biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Curr. Mol. Med. 3(6):509-518.
281. Koch, H.M., H. Drexler, and J. Angerer. 2003. An estimation of the daily intake of di- (2ethyhexyl)phthalate (DEHP) and other phthalates in the general population. Int. J. Hyg. Environ. Health 206(2):77-83.
282. Koch, H.M., H. Drexler, and J. Angerer. 2004. Response to the letter of R.M. David, Int. J. Hyg. Environ. Health 207(1):75-76.
283. Koch, H.M., H. Drexler, and J. Angerer. 2004. Response to the letter of R.M. David, Int. J. Hyg. Environ. Health 207(1):77-78.
284. Kohn, M.C., F. Parham, S.A. Masten, C.J. Portier, M.D. Shelby, J.W. Brock, and L.L., Needham. 2000. Human exposure estimates for phthalates. Environ. Health Perspect. 108(10):A440-A442.
285. Koo, J.W., F. Parham, M.C. Kohn, S.A. Masten, J.W. Brock, L.L. Needham, and C.J. Portier. 2002. The association between biomarker-based exposure estimates for phthalates and demographic factors in a human reference population. Environ. Health Perspect. 110(4): 405-410.
286. Landrigan, P.J., B. Sonawane, D. Mattison, M. McCally, and A. Garg. 2002. Chemical contaminants in breast milk and their impacts on children's health: An overview. Environ. Health Perspect. 110(6):A313-A3155.
287. Lanphear, B.P. 2005. Origins and evolution of children's environmental health. Pp. 24-31 in Essays on the Future of Environmental Health Research: A Tribute to Dr. Kenneth Olden, T.J. Goehl, ed. Research Triangle Park, NC: Environmental Health Perspectives/ National Institute of Environmental Health Sciences [online]. Available: http://ehp.niehs.nih.gov/docs/2005/8003/8003.html [accessed Jan. 20, 2006].
288. Lauwerys, R.R., and P. Hoet. 2001. Industrial Chemical Exposure: Guidelines for Biological Monitoring, 3rd Ed. Boca Raton, FL: Lewis.
289. Lorber, M., and L. Phillips. 2002. Infant exposure to dioxin-like compounds in breast milk. Environ. Health Perspect. 110(6):A325-A332.
290. Lu, C., R. Bravo, L.M. Caltabiano, R.M. Irish, G. Weerasekera, and D.B. Barr. 2005. The presence of dialkylphosphates in fresh fruit juices: Implications for organophosphate pesticide exposure and risk assessment. J. Toxicol. Environ. Health 68(3):209-227.
291. Maier, A., R.E. Savage Jr., and L.T. Haber. 2004. Assessing biomarker use in risk assessment- a survey of practitioners. J. Toxicol. Environ. Health A 67(8-10):687-695.
292. Morgan, M.K., L.S. Sheldon, C.W. Croghan, P.A. Jones, G.L. Robertson, J.C. Chuang, N.K. Wilson, and C.W. Lyu. 2005. Exposures of preschool children to chlorpyrifos and its degradation product 3,5,6-trichloro-2-pyridinol in their everyday environments. J. Expo. Anal. Environ. Epidemiol. 15(4):297-309.
293. Morgan, M.S., and K.H. Schaller. 1999. An analysis of criteria for biological limit values developed in Germany and in the United States. Int. Arch. Occup. Environ. Health 72(4):195-204.
294. Nebert, D.W., R.A. McKinnon, and A. Puga. 1996. Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer. DNA Cell Biol. 15(4):273-280.
295. Noren, K., and D. Merionyte. 2000. Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20-30 years. Chemosphere 40(9-11):1111-1123.
296. NRC (National Research Council). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC: National Academy Press.
297. NRC (National Research Council). 1991. Monitoring Human Tissues for Toxic Substances. Washington, DC: National Academy Press.
298. NRC (National Research Council). 1994. Science and Judgment in Risk Assessment. Washington, DC: National Academy Press.
299. NRC (National Research Council). 2000. Toxicological Effects of Methylmercury. Washington, DC: National Academy Press.
300. Olsen, G.W., T.R. Church, K.J. Hansen, J.M. Burris, J.L. Butenhoff, J.H. Mandel, and L.R. Zobel. 2004. Quantitatitive evaluation of perfluorooctanesulfonate (PFOS) and other fluorochemicals in the serum of children. J. Children's Health 2:53-76.
301. Omenn, G. 2003. On the significance of the Red Book in the evolution of risk assessment and risk management. Hum. Ecol. Risk Assess. 9(5):1155-1168.
302. Pang, Y., D.L. MacIntosh, D.E. Camann, and P.B. Ryan. 2002. Analysis of aggregate exposure to chlorpyrifos in the NHEXAS-Maryland investigation. Environ. Health Perspect. 110(3):235-240.
303. Parks, L.G., J.S. Ostby, C.R. Lambright, B.D. Abbott, G.R. Klinefelter, N.J. Barlow, and L.E. Gray Jr. 2000. The plasticizer DEHP induces malformations by decreasing fetal testosterone syntheseis during sexual differentiation in the male rat. Toxicol. Sci. 58(2): 339-349.
304. Perera, F.P. 1986. New approaches in risk assessment for carcinogens. Risk Anal. 6(2): 195-201.
305. Perera, F.P. 2000. Molecular epidemiology: On the path to prevention? J. Natl. Cancer Inst. 92(8):602-612.
306. Pinsky, P.F., and M.N. Lorber. 1998. A model to evaluate past exposure to 2,3,7,8-TCDD. J Expo. Anal. Environ. Epidemiol. 8(2):187-206.
307. Pirkle, J.L., L.L. Needham, and K. Sexton. 1995. Improving exposure assessment by monitoring human tissues for toxic chemicals. J. Expo. Anal. Environ. Epidemiol. 5(3): 405-424.
308. Poulsen, O.M., J.M. Christensen, E. Sabbioni, and M.T. Van der Venne. 1994. Trace element reference values in tissues from inhabitants of the European Community. V. Review of trace elements in blood, serum and urine and critical evaluation of reference values for the Danish population. Sci. Total Environ. 141(1-3):197-215.
309. Rao, H.V., and D.R. Brown. 1993. A physiologically based pharmacokinetic assessment of tetrachloroethylene in groundwater for a bathing and showering determination. Risk Anal. 13(1):37-49.
310. Rogan, W., and J.H. Ware. 2003. Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter. J. Pediatr. 143(5):687-688.
311. Rothenberg, S.J., A. Poblano, and L. Schnaas. 2000. Brainstem auditory evoked response at five years and prenatal and postnatal blood lead. Neurotoxicol. Teratol. 22(4):503-510.
312. Rothman, N., W.F. Stewart, and P.A. Schulte. 1995. Incorporating biomarkers into cancer epidemiology: A matrix of biomarker and study design categories. Cancer Epidemiol. Biomarkers Prev. 4(4):301-311.
313. Ryan, J.J., and B. Patry. 2001. Body burdens and food exposure in Canada for polybrominated diphenyl ethers (BDEs). Organohalogen Compounds 51:226-229.
314. Ryan, J.J., B. Patry, P. Mills, and G. Beaudoin. 2002. Recent trends in levels of brominated diphenyl ethers in human milks from Canada. Organohalogen Compounds 58:173-176.
315. Schecter, A., M. Pavuk, O. Papke, J.J. Ryan, L. Birnbaum, and R. Rosen. 2003. Polybrominated diphenyl ethers (PBDEs) in U.S. mothers' milk. Environ. Health Perspect. 111(14): 1723-1729.
316. Schroeter-Kermani, C., D. Hel, T. Hermann, and O. Papke. 2000. The German environmental specimen bank-application in trend monitoring of PBDEs in human blood. Organohalogen Compounds. 47:49-52.
317. Schulte, P.A., and F.P. Perera. 1993. Molecular Epidemiology: Principle and Practices. New York: Academy Press.
318. Schulte, P.A., and G. Talaska. 1995. Validity criteria for the use of biological markers of exposure to chemical agents in environmental epidemiology. Toxicology 101(1-2):73- 88.
319. Schulte, P.A., and M. Waters. 1999. Using molecular epidemiology in assessing exposure for risk assessment. Ann. NY Acad. Sci. 895:101-111.
320. Sherlock, J., J. Hislop, D. Newton, G. Topping, and K. Whittle. 1984. Elevation of mercury in human blood from controlled chronic ingestion of methylmercury in fish. Hum. Toxicol. 3(2):117-131.
321. Silva, M.J., D.B. Barr, J.A. Reidy, N.A. Malek, C.C. Hodge, S.P. Caudill, J.W. Brock, L.L., Needham, and A.M. Calafat. 2004. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Study (NHANES) 1999-2000. Environ. Health Perspect. 112(3):331-338.
322. Sobels, F.H. 1977. Some problems associated with the testing for environmental mutagens and a perspective for studies in "comparative mutagenesis". Mutat. Res. 46(4):245-260.
323. Sohn, M.D., T.E. McKone, and J.N. Blancato. 2004. Reconstructing population exposures from dose biomarkers: Inhalation of trichloroethylene (TCE) as a case study. J. Expo. Anal. Environ. Epidemiol. 14(3):204-213.
324. Stern, A.H. 1997. Estimation of the interindividual variability in the one-compartment pharmacokinetic model for methylmercury: Implications for the derivation of a reference dose. Regul. Toxicol. Pharmacol. 25(3):277-288.
325. Stern, A.H., and A.E. Smith. 2003. An assessment of the cord blood: Maternal blood methylmercury ratio: Implications for risk assessment. Environ. Health Perspect. 111(12):1465- 1470.
326. Strandman, T., J. Koistinen, and T. Vartiainen. 2000. Polybrominated diphenyl ethers (PBDEs) in placenta and human milk. Organohalogen Compounds 47:61-64.
327. Sutter, T.R. 1995. Molecular and cellular approaches to extrapolation for risk assessment. Environ. Health Perspect. 103(4):386-389.
328. Swan, S.H., K.M. Main, F. Liu, S.L. Stewart, R.L. Kruse, A.M. Calafat, C.S. Mao, J.B. Redmon, C.L. Ternand, S. Sullivan, and J.L. Teague. 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 113(8):1056-1061.
329. Tan, C., K. Liao, and H.J. Clewell. 2005. Physiologically based pharmacokinetic modeling as a tool to interpret human biomonitoring data. CIIT Activities 25(4):1-6.
330. Tardif, R., S. Laparé, G.L. Plaa, and J. Brodeur. 1991. Effect of simultaneous exposure to toluene and xylene on their respective biological exposure indices in humans. Int. Arch. Occup. Environ. Health 63(4):279-284.
331. Thier, R., T. Bruning, P.H. Roos, H.P. Rihs, K. Golka, Y. Ko, and H.M. Bolt. 2003. Markers of genetic susceptibility in human environmental hygiene and toxicology: The role of selected CYP, NAT, and GST genes. Int. J. Hyg. Environ. Health. 206(3):149-171.
332. Thrall, K.D., R.A. Gies, J. Muniz, A.D. Woodstock, and G. Higgins. 2002. Route-of-entry and brain tissue partition coefficients for common superfund contaminants. J. Toxicol. Environ. Health A. 65(24):2075-2086.
333. Tornqvist, M., and L. Ehrenberg. 2001. Estimation of cancer risk caused by environmental chemicals based on in vivo dose measurement. J. Environ. Pathol. Toxicol. Oncol. 20(4):263-271.
334. Tornqvist, M., and H.H. Landin. 1995. Hemoglobin adducts for in vivo dose monitoring and cancer risk estimation. J. Occup. Environ. Med. 37(9):1077-1085.
335. Vainio, H. 2001. Use of biomarkers in risk assessment. Int. J. Hyg. Environ. Health 204 (2-3):91-102.
336. Viau, C., G. Hakizimana, and M. Bouchard. 2000. Indoor exposure to polycyclic aromatic hydrocarbons and carbon monoxide in traditional houses in Burundi. Int. Arch. Occup. Environ. Health 73(5):331-338.
337. Viau, C. 2002. Biological monitoring of exposure to mixtures. Toxicol. Lett. 134(1-3):9-16.
338. Viau, C. 2005. Biomonitoring in occupational health: Scientific, socio-ethical, and regulatory issues. Toxicol. Appl. Pharmacol. 207(suppl. 2):S347-S353.
339. Wasserman, G.A., X. Liu, N.J. Lolacono, P. Factor-Litvak, J.K. Kline, D. Popovac, N. Morina, A. Musabegovic, N. Vrenezi, S. Capuni-Paracka, V. Lekic, E. Preteni-Redjepi, S. Hadzialjevic, V. Slavkovich, and J.H. Graziano. 1997. Lead exposure and intelligence in 7-year-old children: The Yugoslavia Prospective Study. Environ. Health Perspect. 105(9): 956-962.
340. WHO (World Health Organization). 1995. Inorganic Lead. Environmental Health Criteria 165. Geneva: World Health Organization [online]. Available: http://www.inchem.org/ documents/ehc/ehc/ehc165.htm [accessed Jan. 20, 2006].
341. WHO (World Health Organization). 2001. Biomarkers in Risk Assessment: Validity and Validation. Environmental Health Criteria 222. Geneva: World Health Organization. 238pp [online]. Available: http://www.inchem.org/documents/ehc/ehc/ehc222.htm [accessed Nov. 21, 2005].
342. Whyatt, R.M., D.B. Barr, D.E. Camann, P.L. Kinney, J.R. Barr, H.F. Andrews, L.A. Hoepner, R. Garfinkel, Y. Hazi, A. Reyes, J. Ramirez, Y. Cosme, and F.P. Perera. 2003. Contemporary-use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns. Environ. Health Perspect. 111(5):749-756.
343. Whyatt, R.M., V. Rauh, D.B. Barr, D.E. Camann, H.F. Andrews, R. Garfinkel, L.A. Hoepner, D. Diaz, J. Dietrich, A. Reyes, D. Tang, P.L. Kinney, and F.P. Perera. 2004. Prenatal insecticide exposures and birth weight and length among an urban minority cohort. Environ. Health Perspect. 112(10):1125-1132.
344. Whyatt, R.M., D. Camann, F.P. Perera, V.A. Rauh, D. Tang, P.L. Kinney, R. Garfinkel, H. Andrews, L. Hoepner, and D.B. Barr. 2005. Biomarkers in assessing residential insecticide exposures during pregnancy and effects on fetal growth. Toxicol. Appl. Pharmacol. 206(2):246-254.
345. Wilson, N.K., J.C. Chuang, C. Lyu, R. Menton, and M.K. Morgan. 2003. Aggregate exposures of nine preschool children to persistent organic pollutant at day care and at home. J. Expo. Anal. Environ. Epidemiol. 13(3):187-202.
346. ACMT (American College of Medical Toxicology). 2006. American College of Medical Toxicology, Fairfax, VA [online]. Available: http://www.acmt.net/main [accessed April 4, 2006].
347. Alaszewski, A., and T. Horlick-Jones. 2003. How can doctors communicate information about risk more effectively? BMJ 327(7417):728-731.
348. American College of Physicians. 1990. Occupational and environmental medicine: The internist's role. Ann. Intern. Med. 113(12):974-982.
349. Andrews, C.J. 1998. Giving expert advice. IEEE Technol. Soc. Mag.17(2):5-6.
350. ATSDR (Agency for Toxic Substances and Disease Registry). 2001. A Primer on Health Risk Communication Principles and Practices [online]. Available: http://www.atsdr.cdc.gov/ HEC/primer.html [accessed Nov. 30, 2005].
351. ATSDR (Agency for Toxic Substances and Disease Registry). 2005. Pediatric Environmental Health Specialty Units (PEHSU). U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry [online]. Available: http://www.atsdr.cdc.gov/ HEC/natorg/pehsu.html [accessed April 4, 2006].
352. Balch, G.I., and S.M. Sutton. 1995. Putting the first audience first: Conducting useful evaluation for a risk-related government agency. Risk Anal. 15(2):163-168.
353. Bates, M.N., J.W. Hamilton, J.S. LaKind, P. Langenberg, M. O'Malley, and W. Snodgrass. 2005. Workshop report: Biomonitoring study design, interpretation, and communication- Lessons learned and path forward. Environ. Health Perspect. 113(11):1615-1621.
354. Becker, R.A. 2005. Trace Chemicals in the Human Body: Interpreting Biomonitoring Data in a Risk Context. Presentation at the First Meeting on Human Biomonitoring of Environmental Toxicants, March 21, 2005, Washington, DC.
355. Brown, R.V. 1985. Presenting Risk Management Information to Policymakers: Executive Summary. Technical Report 85-4. Falls Church, VA: Decision Science Consortium, Ltd.
356. Carpenter, R.A. 1995. Communicating environmental science uncertainties. Environ. Prof. 17(2):127-136.
357. CDC (Centers for Disease Control and Prevention). 2005. Third National Report on Human Exposure to Environmental Chemicals. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http:// www.cdc.gov/exposurereport/3rd/pdf/thirdreport.pdf [accessed Sept. 26, 2005].
358. Covello, V.T., and F.W. Allen. 1988. Seven Cardinal Rules of Risk Communication. OPA-87- 020. Office of Policy Analysis, U.S. Environmental Protection Agency, Washington, DC. April 1988.
359. Covello, V.T., P.M. Sandman, and P. Slovic. 1988. Risk Communication, Risk Statistics and Risk Comparisons: A Manual for Plant Managers. Washington, DC: Chemical Manufacturers Association.
360. Cvetkovich, G., and P.L. Winter. 2003. Trust and social representations of the management of threatened and endangered species. Environ. Behav. 35(2):286-307.
361. Cvetkovich, G., M. Siegrist, R. Murray, and S. Tragesser. 2002. New information and social trust: Asymmetry and perseverance of attributions about hazard managers. Risk Anal. 22(2):359-367.
362. Duggan, A. 2005. CropLife America (CLA) Comments. Presentation at the First Meeting on Human Biomonitoring of Environmental Toxicants, March 21, 2005, Washington, DC.
363. Earle, T.C., and G.T. Cvetkovich. 1995. Social Trust: Toward a Cosmopolitan Society. Westport, CT: Praeger.
364. Edwards, J.A., and G. Weary. 1998. Antecedents of causal uncertainty and perceived control: A prospective study. Eur. J. Pers. 12(2):135-148.
365. Einsiedel, E., and B. Thorne. 1999. Public responses to uncertainty. Pp. 43-57 in Communicating Uncertainty: Media Coverage of New and Controversial Science, S.M. Friedman, S. Dunwoody, and C.L. Rogers, eds. Mahwah, NJ: Lawrence Erlbaum Associates.
366. Frewer, L.J., C. Howard, and R. Shepherd. 1998. The influence of initial attitudes on responses to communication about genetic engineering in food production. Agr. Hum. Values 15(1):15-30.
367. Frewer, L.J., S. Miles, M. Brennan, S. Kuznesof, M. Ness, and C. Ritson. 2002. Public preferences for informed choice under conditions of risk uncertainty. Public Underst. Sci. 11(4):363-372.
368. Frewer, L.J., S. Hunt, M. Brennan, S. Kuznesof, M. Ness, and C. Ritson. 2003. The views of scientific experts on how the public conceptualize uncertainty. J. Risk Res. 6(1):75-85.
369. Furnham, A., and T. Ribchester. 1995. Tolerance of ambiguity: A review of the concept, its measurement and applications. Curr. Psychol. 14(3):179-199.
370. GAO (U.S. General Accounting Office). 2000. Toxic Chemicals: Long-term Coordinated Strategy Needed to Measure Exposures in Humans. GAO/HEHS-00-80. U.S. General Accounting Office, Washington, DC. May 2000 [online]. Available: http://www.gao.gov/ new.items/he00080.pdf. [accessed Dec. 1, 2005].
371. Goldman, R.H., S. Rosenwasser, and E. Armstrong. 1999. Incorporating an environmental/ occupational medicine theme into the medical school curriculum. J. Occup. Environ. Med. 41(1):47-52.
372. Grupenhoff, J.T. 1990. Case for a National Association of Physicians for the Environment. Am. J. Ind. Med. 18(5):529-533.
373. Hance, B.J., C. Chess, and P.M. Sandman. 1988. Improving Dialogue with Communities: A Risk Communication Manual for Government. Trenton NJ: New Jersey Department of Environmental Protection.
374. Helsel, D.R. 1990. Less than obvious: Statistical treatment of data below the detection limit. Environ. Sci. Technol. 24(12):1766-1774.
375. Johnson, B.B. 2002a. Risk communication: A mental models approach [book review]. Risk Anal. 22(4):813-814.
376. Johnson, B.B. 2002b. Stability and inoculation of risk comparisons' effects under conflict: Replicating and extending the 'Asbestos Jury' study by Slovic et al. Risk Anal. 22(4):789- 800.
377. Johnson, B.B. 2003a. Further notes on public response to uncertainty in risk and science. Risk Anal. 23(4):781-789.
378. Johnson, B.B. 2003b. Are some risk comparisons more effective under conflict? A replication and extension of Roth et al. Risk Anal. 23(4):767-780.
379. Johnson, B.B. 2003c. Do reports on drinking water quality affect customers' concerns? Experiments in report content. Risk Anal. 23(5):985-998.
380. Johnson, B.B. 2004a. Erratum to "Further notes on public response to uncertainty in risks and science" by Branden B. Johnson, in Risk Analysis, 23(4), 2003. Risk Anal. 24(3):781.
381. Johnson, B.B. 2004b. Risk comparisons, conflict, and risk acceptability claims. Risk Anal. 24(1):131-145.
382. Johnson, B.B., and C. Chess. 2003. How reassuring are risk comparisons to pollution standards and emission limits? Risk Anal. 23(5):999-1007.
383. Johnson, B.B., and P. Slovic. 1995. Presenting uncertainty in health risk assessment: Initial studies of its effects on risk perception and trust. Risk Anal. 15(4):485-494.
384. Johnson, B.B., and P. Slovic. 1998. Lay views on uncertainty in environmental health risk assessment. J. Risk Res. 1(4):261-279.
385. Jonas, E., J. Greenberg, and D. Frey. 2003. Connecting terror management and dissonance theory: Evidence that mortality salience increases the preference for supporting information after decisions. Pers. Soc. Psychol. B. 29(9):1181-1189.
386. Kraus, N., T. Malmfors, and P. Slovic. 1992. Intuitive toxicology: Expert and lay judgments of chemical risks. Risk Anal. 12(2):215-232.
387. Krewski, D., P. Slovic, S. Bartlett, J. Flynn, and C.K. Mertz. 1995. Health risk perception in Canada II: Worldviews, attitudes and opinions. Hum. Ecol. Risk Assess. 1(3):231-248.
388. Lopes, L.L. 1983. Some thoughts on the psychological concept of risk. J. Exp. Psychol. Human 9:137-144.
389. MacGregor, D.G., P. Slovic, and T. Malmfors. 1999. "How exposed is exposed enough?" Lay inferences about chemical exposure. Risk Anal. 19(4):649-659.
390. Maynard, D.W. 2003. Bad News, Good News: Conversational Order in Everyday Talk and Clinical Settings. Chicago: University of Chicago Press.
391. McCallum, D.B., and S.L. Santos. 1994. Public Knowledge and Perceptions of Chemical Risks in Six Communities. Follow-Up Survey Results. Final Report to the U.S. Environmental Protection Agency. New York: Columbia University, Center for Risk Communication.
392. McCallum, D.B., and S.L. Santos. 1996. Participation and persuasion: A communications perspective on risk management. Pp 16.1-16.32 in Risk Assessment and Management Handbook: For Environmental, Health, and Safety Professionals, R.V. Kolluru, S.M. Bartell, R.M. Pitblado, and R.S. Stricoff, eds. New York: McGraw Hill.
393. Miles, S., and L.J. Frewer. 2003. Public perception of scientific uncertainty in relation to food hazards. J. Risk Res. 6(3):267-284.
394. Morgan, M.G., and L. Lave. 1990. Ethical considerations in risk communication practice and research. Risk Anal. 10(3):355-358.
395. Morgan, M.G., B. Fischhoff, A. Bostrom, and C.J. Atman. 2002. Risk Communication: A Mental Models Approach. New York: Cambridge University Press.
396. NRC (National Research Council). 1989. Improving Risk Communication. Washington, DC: National Academy Press.
397. NRC (National Research Council). 1994. Science and Judgment in Risk Assessment. Washington, DC: National Academy Press.
398. NRC (National Research Council). 1997. Building a Foundation for Sound Environmental Decisions. Washington, DC: National Academy Press.
399. NRC (National Research Council). 2004. Adaptive Management for Water Resources Project Planning. Washington, DC: The National Academies Press.
400. O'Connor, A.M., F. Légaré, and D. Stacey. 2003. Risk communication in practice: The contribution of decision aids. BMJ 327(7417):736-740.
401. Osterloh, J. 2005. Biomonitoring: Attributes and Applications. Presentation at the First Meeting on Human Biomonitoring of Environmental Toxicants, March 21, 2005, Washington, DC.
402. Otway, H., and B. Wynne. 1989. Risk communication: Paradigm and paradox. Risk Anal. 9(2):141-145.
403. Paling, J. 2003. Strategies to help patients understand risks. BMJ 327(7417):745-748.
404. PCCRARM (Presidential/Congressional Commission on Risk Assessment and Risk Management). 1997. Risk Assessment and Risk Management in Regulatory Decision-Making. Final Report. Washington, DC: U.S. General Printing Office [online]. Available: http:// www.riskworld.com/Nreports/1997/risk-rpt/volume2/pdf/v2epa.PDF [accessed Dec. 1, 2005].
405. Pflugh, K.K., J.A. Shaw, and B.B. Johnson. 1994. Establishing Dialogue: Planning for Successful Environmental Management; A Guide to Effective Communication Planning. Trenton, NJ: New Jersey Department of Environmental Protection and Energy.
406. Pirkle, J.L., L.L. Needham, and K. Sexton. 1995. Improving exposure assessment by monitoring human tissues for toxic chemicals. J. Expo. Anal. Environ. Epidemiol. 5(3):405-424.
407. Renn, O., T. Webler, and B.B. Johnson. 1991. Public participation in hazard management: The use of citizen panels in the U.S. Risk Issues Health Safety 2(3):197-226.
408. Renn, O., T. Webler, and P. Wiedemann, eds. 1995. Fairness and Competence in Citizen Participation: Evaluating Models for Environmental Discourse. Dordrecht, The Netherlands: Kluwer.
409. Rimer, B.K., and B. Glassman. 1998. Tailoring communications for primary care settings. Methods Inf. Med. 37(2):171-177.
410. Robison, S.H. 2005. Biomonitoring. Presentation at the First Meeting on Human Biomonitoring of Environmental Toxicants, March 21, 2005, Washington, DC.
411. Roth, E., M.G. Morgan, B. Fischhoff, L. Lave, and A. Bostrom. 1990. What do we know about making risk comparisons? Risk Anal. 10(3):375-387.
412. Rowan, K.E. 1994. Why rules for risk communication are not enough: A problem-solving approach to risk communication. Risk Anal. 14(3):365-374.
413. Schober, S. 2005. National Health and Nutrition Examination Survey (NHANES): Environmental Biomonitoring Measures, Interpretation of Results. Presentation at the Second Meeting on Human Biomonitoring of Environmental Toxicants, April 28, 2005, Washington, DC.
414. Schulte, P.A., and G. Talaska. 1995. Validity criteria for the use of biological markers of exposure to chemical agents in environmental epidemiology. Toxicology 101(1-2): 73-88.
415. Schwartz, L.M., S. Woloshin, and H.G. Welch. 1999. Risk communication in clinical practice: Putting cancer in context. J. Natl. Cancer Inst. Monogr. 25:124-133.
416. Sexton, K., L.L. Needham, and J.L. Pirkle. 2004. Human biomonitoring of environmental chemicals: Measuring chemicals in human tissue is the "gold standard" for assessing the people's exposure to pollution. Am. Sci. 92(1):39-45.
417. Sherman, D.A.K., L.D. Nelson, and C.M. Steele. 2000. Do messages about health risks threaten the self? Increasing the acceptance of threatening health messages via selfaffirmation. Pers. Soc. Psychol. B. 26(9):1046-1058.
418. Siegrist, M., and G. Cvetkovich. 2001. Better negative than positive? Evidence of a bias for negative information about possible health dangers. Risk Anal. 21(1):199-206.
419. Siegrist, M., T.C. Earle, and H. Gutscher. 2003. Test of a trust and confidence model in the applied context of electromagnetic field (EMF) risks. Risk Anal. 23(4):705-716.
420. Slovic, P. 1993. Perceived risk, trust, and democracy. Risk Anal. 13(6):675-682.
421. Stern, P.C. 1991. Learning through conflict: A realistic strategy for risk communication. Policy Sci. 24(1):99-119.
422. Stern, P.C., and H.V. Fineberg, eds. 1996. Understanding Risk: Informing Decisions in a Democratic Society. Washington, DC: National Academy Press.
423. Thompson, K.M., and D.L. Bloom. 2000. Communication of risk assessment information to risk managers. J. Risk Res. 3(4):333-352.
424. Timotijevic, L., and J. Barnett. 2006. Managing the possible health risks of mobile telecommunications: Public understandings of precautionary action and advice. Health Risk Soc. 8(2):143-164.
425. Van Damme, K., and L. Casteleyn. 2003. Current scientific, ethical and social issues of biomonitoring in the European Union. Toxicol. Lett. 144(1):117-126.
426. Weinstein, N.D. 1986. Public Perceptions of Environmental Hazards; Study 1 Final Report: Statewide Poll of Environmental Perceptions. Trenton, NJ: New Jersey Department of Environmental Protection, Office of Science and Research.
427. Wenger, D.E. 1987. Collective behavior and disaster research. Pp. 213-238 in Sociology of Disasters: Contribution of Sociology to Disaster Research, R.R. Dynes, B. De Marchi, and C. Pelanda, eds. Milan, Italy: Franco Angeli Libri.
428. White, M.P., and J.R. Eiser. 2005. Information specificity and hazard risk potential as moderators of trust asymmetry. Risk Anal. 25(5):1187-1198.
429. White, M.P., and J.R. Eiser. In press. Marginal trust in risk managers: Building and losing trust following decisions under uncertainty. Risk Analysis.
430. White, M.P., S. Pahl, M. Buehner, and A. Haye. 2003. Trust in risky messages: The role of prior attitudes. Risk Anal. 23(4):717-726.
431. Wiedemann, P.M., and H. Schutz. 2005. The precautionary principle and risk perception: Experimental studies in the EMF area. Environ. Health Perspect. 113(4):402-405.
432. Wynn, P.A., N.R. Williams, D. Snashall, and T.C. Aw. 2003. Undergraduate occupational health teaching in medical schools-not enough of a good thing? Occup. Med. 53(6):347- 348.
433. APHL (Association of Public Health Laboratories). 2006. APHL Minute Newsletter 1:12-14 [online]. Available: http://www.aphl.org/docs/newsletter/january_february_3.pdf [accessed Feb. 1, 2006].
434. Barr, D.B., R.Y. Wang, and L.L. Needham. 2005. Biologic monitoring of exposure to environmental chemicals throughout the life stages: Requirements and issues for consideration for the National Children's Study. Environ. Health Perspect. 113(8):1083-1091.
435. Borrell, L.N., P. Factor-Litvak, M.S. Wolff, E. Susser, and T.D. Matte. 2004. Effect of socioeconomic status on exposures to polychlorinated biphenyls (PCBs) and dichlordiphenyldichloroethylene (DDE) among pregnant African-American women. Arch. Environ. Health 59(5):250-255.
436. Buchanan, J.R., L.T. Burka, and R.L. Melnick. 1997. Purpose and guidelines for toxicokinetic studies within the National Toxicology Program. Environ. Health Perspect. 105(5):468-471.
437. CDC (Centers for Disease Control and Prevention). 2005. Third National Report on Human Exposure to Environmental Chemicals. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http:// www.cdc.gov/exposurereport/3rd/pdf/thirdreport.pdf [accessed Sept. 26, 2005].
438. CMS (Center for Medicare and Medicaid Services). 2005. CLIA Approved Proficiency Testing Programs-2005 [online]. Available: http://new.cms.hhs.gov/CLIA/downloadsptlist.pdf [accessed Feb. 1, 2006].
439. CLSI (Clinical Laboratory Standards Institute). 2006. CLSI Standards Development [online]. Available: http://www.clsi.org/Content/NavigationMenu/StandardsDevelopment/CLSI StandardsDevelopment/default.htm [accessed Feb. 16, 2006].
440. Eskenazi, B., E. Gladstone, G. Berkowitz, C. Drew, E. Faustman, N.T. Holland, S. Lanphear, S. Meilsel, F. Perera, V. Rauh, A. Sweeney, R. Whyatt, and K. Yolton. 2005. Methodologic and logistic issues in conducting longitudinal birth cohort studies: Lessons learned from the Center of Children's Environmental Health and Disease Prevention Research. Environ. Health Perspect. 113(10):1419-1429.
441. GAO (U.S. General Accounting Office). 2000. Toxic Chemicals: Long-Term Coordinated Strategy Needed to Measure Exposures in Humans. GAO/HEHS-00-80. U.S. General Accounting Office, Washington, DC. May 2000 [online]. Available: http://www.gao.gov/ new.items/he00080.pdf [accessed June 3, 2005].
442. Gray, K.A., M.A. Klebanoff, J.W. Brock, H. Zhou, R. Darden, L. Needham, and M.P. Longnecker. 2005. In utero exposure to background levels of polychlorinated biphenyls and cognitive functioning among school-age children. Am. J. Epidemiol. 162(1):17-26.
443. Gwynn, C., and L. Thorpe. 2004. New York City HANES: Advancing Local Public Health and Nutrition Surveillance. Abstract 92319 in Program and Abstracts of the American Public Health Association 132nd Annual Meeting; November 6-10, 2004; Washington, DC [online]. Available: http://apha.confex.com/apha/132am/techprogram/paper_92319.htm [accessed Feb. 1, 2006].
444. Holland, N.T., L. Pfleger, E. Berger, A. Ho, and M. Bastaki. 2005. Molecular epidemiology biomarkers: Sample collection and processing considerations. Toxicol. Appl. Pharmacol. 206(2):261-268.
445. Longnecker, M.P., M.A. Klebanoff, J.W. Brock, and X. Guo. 2005. Maternal levels of polychlorinated biphenyls in relation to preterm and small-for-gestational-age birth. Epidemiology 16(5):641-647.
446. NCHS (National Center for Health Statistics). 2005. National Health and Nutrition Examination Survey. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, MD [online]. Available: http://www.cdc.gov/nchs/nhanes.htm [accessed May 2, 2006].
447. NCS (National Children's Study). 2005. The NCS Herald Study-An NCS Pilot Cohort [online]. Available: http://www.nationalchildrensstudy.gov/events/ncsac/2005_April/ loader.cfm?url=/commonspot/security getfile.cfm&PageID=10473&CFID=4135254& CFTOKEN=15157050 [accessed June 3, 2005].
448. Needham, L.L. 2005. Biomonitoring in NHANES and Other Programs. Presented at the Second Meeting on Human Biomonitoring for Environmental Toxicants, April 28, 2005, Washington, DC.
449. NTP (National Toxicology Program). 1993a. NTP Technical Report on Toxicity Studies of a Chemical Mixture of 25 Groundwater Contaminants Administered in Drinking Water to F344/N Rats and B6C3F1 Mice. NIH Publication 93-3384. U.S. Department of Health and Human Services, National Institutes of Health, Research Triangle Park, NC. August 1993.
450. NTP (National Toxicology Program). 1993b. NTP Technical Report on Toxicity Studies of Pesticide/Fertilizer Mixtures Administered in Drinking Water to F344/N Rats and B6C3F1 Mice. NIH Publication 93-3385. U.S. Department of Health and Human Services, National Institutes of Health, Research Triangle Park, NC. July 1993.
451. Poulin, P., and F.P. Theil. 2002. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition. J. Pharm. Sci. 91(5):1358-1370.
452. Poulin, P., K. Schoenlein, and F.P. Theil. 2001. Prediction of adipose tissue: Plasma partition coefficient for structurally unrelated drugs. J. Pharm. Sci. 90(4):436-447.
453. Reddy, M.B., R.S.H. Yang, H.J. Clewell III, and M.E. Andersen. 2005. Physiologically Based Pharmacokinetics: Science and Applications. Hoboken, NJ: Wiley-Interscience.
454. Rigas, M.L., M.S. Okino, and J.J. Quackenboss. 2001. Use of a pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurements. Toxicol. Sci. 61(2):374-381.
455. Schober, S. 2005. National Health and Nutrition Examination Survey (NHANES): Environmental Biomonitoring Measures, Interpretation of Results. Presented at the Second Meeting on Human Biomonitoring for Environmental Toxicants, April 28, 2005, Washington, DC.
456. van de Waterbeemd, H., and E. Gifford. 2003. ADMET in silico modeling: Towards prediction paradise? Nat. Rev. Drug Discov. 2(3):192-204.
457. Vermeulen R., Q. Lan, L. Zhang, L. Gunn, D. McCarthy, R.L. Woodbury, M. McGuire, V.N. Podust, G. Li, N. Chatterjee, R. Mu, S. Yin, N. Rothman, and M.T. Smith. 2005. Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics. Proc. Natl. Acad. Sci. USA 102(47):17041-17046.
458. Weis, B.K., D. Balshawl, J.R. Barr, D. Brown, M. Ellisman, P. Lioy, G. Omenn, J.D. Potter, M.T. Smith, L. Sohn, W.A. Suk, S. Sumner, J. Swenberg, D.R. Walt, S. Watkins, C. Thompson, and S.H. Wilson. 2005. Personalized exposure assessment: Promising approaches for human environmental health research. Environ. Health Perspect. 113(7): 840-848.
459. Wild, C.P. 2005. Complementing the genome with an "exposome": The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 14(8):1847-1850.
460. Yang, R.S.H. 1994. Toxicology of chemical mixtures derived from hazardous waste sites or application of pesticides and fertilizers. Pp. 99-117 in Toxicology of Chemical Mixtures: Case Studies, Mechanisms, and Novel Approaches. San Diego, CA: Academic Press.
461. Yang, R.S.H., H.A. El-Masri, R.S. Thomas, I.D. Dobrev, J.E. Dennison, Jr., D.S. Bae, J.A. Campain, K.H. Liao, B. Reisfeld, M.E. Andersen, and M. Mumtaz. 2004. Chemical mixture toxicology: From descriptive to mechanistic, and going on to in silico toxicology. Environ. Toxicol. Pharmacol. 18(2):65-81.
462. Yang, R.S.H., A.N. Mayeno, K.H. Liao, K.F. Reardon, and B. Reisfeld. 2005. Integration of PBPK and reaction network modeling: Predictive xenobiotic metabolomics. ALTEX 22(Spec. 2):328-334.
463. Zartarian, V.G., H. Ozkaynak, J.M. Burke, M.J. Zufall, M.L. Rigas, and E.J. Furtaw Jr. 2000. A modeling framework for estimating children's residential exposure and dose to chlorpyrifos via dermal residue contact and nondietary ingest. Environ. Health Perspect. 108(6):505-514.
464. Abraham, K., R. Krowke, and D. Neubert. 1988. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection. Arch. Toxicol. 62(5):359-368.
465. ACGIH (American Conference of Governmental Industrial Hygienists). 1991. Documentation of the Threshold Limit Values and Biological Exposure Indices, 6th Ed. American Conference of Governmental Industrial Hygienists, Cincinnati, OH.
466. Acquavella, J.F., B.H. Alexander, J.S. Mandel, C. Gustin, B. Baker, P. Chapman, and M. Bleeke. 2004. Glyphosate biomonitoring for farmers and their families: Results from the Farm Family Exposure Study. Environ. Health Perspect. 112(3):321-326.
467. ATSDR (Agency for Toxic Substances and Disease Registry). 2003. Toxicological Profile for Pyrethrins and Pyrethroids. U.S. Department of Health and Human Service, Public Health Service, Agency for Toxic Substances and Disease Registry Service [online]. Available:http://www.atsdr.cdc.gov/toxprofiles/tp155.html [accessed Jan. 19, 2006].
468. Barr, D.B., R. Allen, A.O. Olsson, R. Bravo, L.M. Caltabiano, A. Montesano, J. Nguyen, S. Udunka, D. Walden, R.D. Walker, G. Weerasekera, R.D. Whitehead Jr, S.E. Schober, and L.L. Needham. 2005. Concentrations of selective metabolites of organophosphorus pesticides in the United States population. Environ. Res. 99(3):314-326.
469. Berkowitz, G.S., J. Obel, E. Deych, R. Lapinski, J. Godbold, Z. Liu, P.J. Landrigan, and M.S. Wolff. 2003. Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort. Environ. Health Perspect. 111(1):79-84.
470. Berkowitz, G.S., J.G. Wetmur, E. Birman-Deych, J. Obel, R.H. Lapinski, J.H. Godbold, I.R. Holzman, and M.S. Wolff. 2004. In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ. Health Perspect. 112(3):388-391.
471. Carrier, G., R.C. Brunet, and J. Brodeur. 1995. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. I. Nonlinear distribution of PCDD/PCDF body burden between liver and adipose tissues. Toxicol. Appl. Pharmacol. 131(2):253-266.
472. Carrington, C.D., and M.P. Bolger. 2002. An exposure assessment for methylmercury from seafood for consumers in the United States. Risk Anal. 22(4):689-99.
473. CDC (Centers for Disease Control and Prevention). 2005. Third National Report on Human Exposure to Environmental Chemicals. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA [online]. Available: http:// www.cdc.gov/exposurereport/3rd/ [accessed Nov. 16, 2005].
474. Clewell, H.J., and K.S. Crump. 2005. Quantitative estimates of risk for noncancer endpoints. Risk Anal. 25(2):285-289.
475. Clewell, H.J., P.R. Gentry, T.R. Covington, and J.M. Gearhart. 2000. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ. Health Perspect. 108(Suppl. 2):283-306.
476. Droz, P.O., and M.P. Guillemin. 1983. Human styrene exposure. V. Development of a model for biological modeling. Int. Arch. Occup. Environ. Health 53(1):19-36.
477. Emond, E., M. Charbonneau, and K. Krishnan. 2005a. Physiologically based modeling of the accumulation in plasma and tissue lipids of a mixture of PCB congeners in female Sprague-Dawley rats. J. Toxicol. Environ. Health A 68(16):1393-1412.
478. Emond, C, J.E. Michalek, L.S. Birnbaum, and M.J. DeVito. 2005b. Comparison of the use of a physiologically based pharmacokinetic model and a classical pharmacokinetic model for dioxin exposure assessment. Environ. Health Perspect. 113(12):1666-1668.
479. EPA (U.S. Environmental Protection Agency). 1998. Styrene (CASRN 100-42-5). Integrated Risk Information System, U.S. Environmental Protection Agency [online]. Available: http://www.epa.gov/iris/subst/0104.htm [accessed Jan. 17, 2006].
480. EPA (U.S. Environmental Protection Agency). 2003. Exposure and Human Health Reassessment of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds National Academy Sciences (NAS) Review Draft, Oct, 2004 [online]. Available: http:// www.epa.gov/ncea/pdfs/dioxin/nas-review/ [accessed Jan. 20, 2006].
481. Fisher, J.W., D. Mahle, and R. Abbas. 1998. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. Toxicol Appl Pharmacol. 152(2):339-359.
482. Grandjean, P., P. Weihe, R.F. White, F. Debes, S. Araki, K. Yokoyama, K. Murata, N. Sorensen, R. Dahl, and P.J. Jorgensen. 1997. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol. Teratol. 19(6):417-428.
483. Harkonen, H. 1977. Relationship of symptoms to occupational styrene exposure and to the findings of electroencephalographic and psychological examinations. Int. Arch. Occup. Environ. Health 40(4):231-239.
484. Kjellström, T., P. Kennedy, S. Wallis, and C. Mantell. 1986. Physical and Mental Development of Children with Prenatal Exposure to Mercury from Fish. Stage 1: Preliminary Test at Age 4. Report 3080. Solna, Sweden: National Swedish Environmental Protection Board.
485. Kjellström, T., P. Kennedy, S. Wallis, A. Stewart, L. Friberg, B. Lind, T. Wutherspoon, and C. Mantell. 1989. Physical and Mental Development of Children with Prenatal Exposure to Mercury from Fish. Stage 2: Interviews and Psychological Tests at Age 6. Report 3642. Solna, Sweden: National Swedish Environmental Protection Board.
486. LaKind, J.S., C.M. Berlin, C.N. Park, D.Q. Naiman, and N.J. Gudka. 2000. Methodology for characterizing distributions of incremental body burdens of 2,3,7,8-TCDD and DDE from breast milk in North American nursing infants. J. Toxicol. Environ. Health A 59(8):605-639.
487. Lindstrom, F.T., J.W. Gillett, and S.E. Rodecap. 1976a. Distribution of HEOD (dieldrin) in mammals: III. Transport-transfer. Arch. Environ. Contam. Toxicol. 4(3):257-288.
488. Lindstrom, K., H. Harkonen, and S. Hernberg. 1976b. Disturbances in psychological functions of workers occupationally exposed to styrene. Scand. J. Work Environ. Health 2(3):129-139.
489. Lorber, M., and L. Phillips. 2002. Infant exposure to dioxin-like compounds in breast milk. Environ. Health Perspect. 110(6):A325-A332.
490. Lu, C., R. Bravo, L.M. Caltabiano, R.M. Irish, G. Weerasekera, and D.B. Barr. 2005. The presence of dialkylphosphates in fresh fruit juices: Implications for organophosphate pesticide exposure and risk assessment. J. Toxicol. Environ. Health 68(3):209-227.
491. Lutz, R.J., R.L. Dedrick, D. Tuey, I.G. Sipes, M.W. Anderson, and H.B. Matthews. 1984. Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model. Drug Metab. Dispos. 12(5):527-535.
492. Mahaffey, K.R., R.P. Clickner, and C.C. Bodurow. 2004. Blood organic mercury and dietary mercury intake: National Health and Nutrition Examination Survey, 1999 and 2000. Environ. Health Perspect. 112(5):562-570.
493. Michalek, J.E., J.L. Pirkle, S.P. Caudill, R.C. Tripathi, D.G. Patterson Jr., and L.L. Needham. 1996. Pharmacokinetics of TCDD in veterans of Operation Ranch Hand: 10-year followup. J. Toxicol. Environ. Health 47(3):209-220.
494. Migliore, L., A. Naccarati, A. Zanello, R. Scarpato, L. Bramanti, and M. Mariani. 2002. Assessment of sperm DNA integrity in workers exposed to styrene. Hum. Reprod. 17(11):2912-2918.
495. Morgan, M.K., L.S. Sheldon, C.W. Croghan, P.A. Jones, G.L. Robertson, J.C. Chuang, N.K. Wilson, and C.W. Lyu. 2005. Exposures of preschool children to chlorpyrifos and its degradation product 3,5,6-trichloro-2-pyridinol in their everyday environments. J. Expo. Anal. Environ. Epidemiol. 15(4):297-309.
496. Mutti, A., A. Mazzucchi, P. Rustichelli, G. Frigeri, G. Arfini, and I. Franchini. 1984. Exposure- effect and exposure-response relationships between occupational exposure to styrene and neuropsychological functions. Am. J. Ind. Med. 5(4):275-286.
497. Myers, G.J., P.W. Davidson, C. Cox, C.F. Shamlaye, D. Palumbo, E. Cernichiari, J. Sloane- Reeves, G.E. Wilding, J. Kost, L.S. Huang, and T.W. Clarkson. 2003. Prenatal methyl mercury exposure from ocean fish consumption in the Seychelle child development study. Lancet 361(9370):1686-1692.
498. Needham, L.L. 2005. Assessing exposure to organophosphorus pesticides by biomonitoring in epidemiologic studies of birth outcomes. Environ. Health Perspect. 113(4):494-498.
499. NRC (National Research Council). 2000. Toxicological Effects of Methylmercury. Washington, DC: National Academy Press.
500. Ott, M.G., and A. Zober. 1996. Cause specific mortality and cancer incidence among employees exposed to 2,3,7,8-TCDD after a 1953 reactor accident. Occup. Environ. Med. 53(9):606-612.
501. Pang, Y., D.L. Macintosh, D.E. Camann, and P.B. Ryan. 2002. Analysis of aggregate exposure to chlorpyrifos in the NHEXAS-Maryland investigation. Environ. Health Perspect. 110(3):235-240.
502. Pirkle, J.L., W.H. Wolfe, D.G. Patterson, L.L. Needham, J.E. Michalek, J.C., Miner, M.R. Peterson, and D.L. Phillips. 1989. Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo- p-dioxin in Vietnam Veterans of Operation Ranch Hand. J. Toxicol. Environ. Health 27(2):165-171.
503. Rice, D.C., R. Schoeny, and K. Mahaffey. 2003. Methods and rationale for derivation of a reference dose for methylmercury by the U.S. EPA. Risk Anal. 23(1):107-115.
504. Rigas, M.L., M.S. Okino, and J.J. Quackenboss. 2001. Use of a pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurements. Toxicol. Sci. 61(2):374-381.
505. Shafer, T.J., D.A. Meyer, and K.M. Crofton. 2005. Developmental neurotoxicity of pyrethroid insecticides: Critical review and future research needs. Environ. Health Perspect. 113(2):123-136.
506. Shurdut, B.A., L. Barraj, and M. Francis. 1998. Aggregate exposures under the Food Quality Protection Act: An approach using chlorpyrifos. Regul. Toxicol. Pharmacol. 28(2): 165-177.
507. Sohn, M.D., T.E. McKone, and J.N. Blancato. 2004. Reconstructing population exposures from dose biomarkers: Inhalation of trichloroethylene (TCE) as a case study. J. Expo. Anal. Environ. Epidemiol. 14(3):204-213.
508. Stern, A.H., M. Gochfeld, C. Weisel, and J. Burger. 2001. Mercury and methylmercury exposure in the New Jersey pregnant population. Arch Environ Health. 56(1):4-10.
509. Timchalk, C., R.J. Nolan, A.L. Mendrala, D.A. Dittenber, K.A. Brzak, and J.L. Mattsson. 2002. A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. Toxicol. Sci 66(1): 34-53.
510. van der Molen, G.W., S.A. Kooijman, and W. Slob. 1996. A generic toxicokinetic model for persistent lipophilic compounds in humans: An application to TCDD. Fundam. Appl. Toxicol. 31(1):83-94.
511. Vyskocil, A., S. Emminger, F. Malir, Z. Fiala, M. Tusl, E. Ettlerova, and A. Bernard. 1989. Lack of nephrotoxicity of styrene at current TLV level (50 ppm). Int. Arch. Occup. Environ. Health 61(6):409-411.
512. Whyatt, R.M., V. Rauh, D.B. Barr, D.E. Camann, H.F. Andrews, R. Garfinkel, L.A. Hoepner, D. Diaz, J. Dietrich, A. Reyes, D. Tang, P.L. Kinney, and F.P. Perera. 2004. Prenatal insecticide exposures and birth weight and length among an urban minority cohort. Environ. Health Perspect. 112(10):1125-1132.
513. Wilson, N.K., J.C. Chuang, C. Lyu, R. Menton, and M.K. Morgan. 2003. Aggregate exposures of nine preschool children to persistent organic pollutant at day care and at home. J. Expo. Anal. Environ. Epidemiol. 13(3):187-202.
514. Andersen, M.E. 1987. Tissue dosimetry in risk assessment, or what's the problem here anyway? Pp. 8-23 in Pharmacokinetics in Risk Assessment. Drinking Water and Health, Vol. 8. Washington, DC: National Academy Press.
515. Andersen, M.E., H.J. Clewell III, M.L. Gargas, F.A. Smith, and R.H. Reitz. 1987. Physiologically- based pharmacokinetics and the risk assessment for methylene chloride. Toxicol. Appl. Pharmacol. 87(2):185-205.
516. Bischoff, K.B., and R.G. Brown. 1966. Drug distribution in mammals. Chem. Eng. Prog. Symp. Ser. 62(66):33-45.
517. Brown, R.P., M.D. Delp, S.L. Lindstedt, L.R. Rhomberg, and R.P. Beliles. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13(4):407-484.
518. Dedrick, R.L. 1973. Animal scale-up. J. Pharmacokinet. Biopharm. 1(5):435-461.
519. Krishnan, K., S. Haddad, M. Beliveau, and R. Tardif. 2002. Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixtures. Environ. Health Perspect. 110(Suppl. 6):989-994.
520. Kedderis, G.L., and J.C. Lipscomb. 2001. Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment. Toxicol. Ind. Health 17(5-10):315-321.
521. Lindstedt, S.L. 1987. Allometry: Body size constraints in animal design. Pp. 65-79 in Pharmacokinetics in Risk Assessment. Drinking Water and Health, Vol. 8. Washington, DC: National Academy Press.
522. Lipscomb, J.C., J.W. Fisher, P.D. Confer, and J.Z. Byczkowski. 1998. In vitro to in vivo extrapolation for trichloroethylene metabolism in humans. Toxicol. Appl. Pharmacol. 152(2):376-387.
523. Ramsey, J.C., and M.E. Andersen. 1984. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73(1):159- 175.
524. Reddy, M.B., R.S.H. Yang, H.J. Clewell III, and M.E. Andersen. 2005. Physiologically Based Pharmacokinetic (PBPK) Modeling: Science and Applications. Hoboken, NJ: Wiley. 420 pp.
525. van de Waterbeemd, H., and E. Gifford. 2003. ADMET in silico modeling: Towards prediction paradise. Nat. Rev. Drug Discov. 2(3):192-204.
526. Yang, R.S.H., and M.E. Andersen. 2005. PBPK modeling of chemical mixtures. Pp. 349-373 in Physiologically Based Pharmacokinetic (PBPK) Modeling: Science and Applications, M.B. Reddy, R.S.H. Yang, H.J. Clewell III, and M.E. Andersen, eds. Hoboken, NJ: Wiley.
527. Yang, R.S.H., M.E. Andersen, J.E. Dennison, Y.C. Ou, K.H. Liao, and B. Reisfeld. 2004. Physiologically based pharmacokinetic and pharmacodynamic modeling. Pp. 391-405 in Mouse Models of Cancer, E.C. Holland, ed. Hoboken, NJ: Wiley.
528. Yang, R.S.H., A.N. Mayeno, K.H. Liao, K.F. Reardon, and B. Reisfield. 2005. Integration of PBPK and Reaction Network Modelling: Predictive Xenobiotic Metabolomics. ALTEX. 22(Special Issue 2):328-334.